fibrinogen has been researched along with Benign Neoplasms in 349 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 228 (65.33) | 18.7374 |
| 1990's | 21 (6.02) | 18.2507 |
| 2000's | 41 (11.75) | 29.6817 |
| 2010's | 35 (10.03) | 24.3611 |
| 2020's | 24 (6.88) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Qian, W; Wang, R; Zhao, M | 1 |
| Araya, E; Cordero, ML; Hassan, N; Juárez, J; Kogan, MJ; Orellana, N; Palma, S; Ruso, JM; Topete, A; Torres, E; Vasquez-Contreras, R; Vio, V | 1 |
| Alolga, RN; Liu, Q; Liu, XH; Qi, LW | 1 |
| Jiang, T; Liu, YJ; Lv, Y; Ma, N; Shi, AP; Shi, XG; Tang, XY; Xiong, YL; Zhao, JB; Zheng, KF | 1 |
| Argyrou, S; Dreden, PV; Gerotziafas, G; Glantzounis, G; Karakosta, A; Lefkou, E; Pantazi, D; Papapetrou, E; Stratigopoulou, P; Tselepis, A; Tzimas, P | 1 |
| Fu, WJ; Huo, JL; Liu, ZS; Lu, N; Wang, YT | 1 |
| Fox, LE; Henson, MS; Husbands, BD; Johannes, CM; Kim, JH; LeVine, DN; Makielski, KM; Modiano, JF; Rendahl, AK; Schulte, AJ; Walz, JZ | 1 |
| Jonderko, L; Karłowicz-Bodalska, K; Kulbacka, J; Kunachowicz, D; Oślizło, M; Sauer, N; Szlasa, W | 1 |
| Palumbo, JS | 1 |
| Connors, JM; Iba, T | 1 |
| Isachenko, E; Isachenko, V; Liu, W; Mallmann, P; Pei, C; Rahimi, G; Wang, M; Wang, W; Zhou, Y | 1 |
| Angelidakis, E; Chen, S; Kamm, RD; Shelton, SE; Wan, Z; Zhang, S | 1 |
| Deng, L; Ge, L; Guo, F; Li, C; Li, Z; Liu, X; Qian, H; Qiu, S; Xu, B; Yang, L; Zhai, J | 1 |
| Deng, H; Lei, J; Li, Y; Liu, X; Wu, L; Zhang, J; Zhang, N; Zhao, H | 1 |
| Cao, H; Cui, X; Guo, H; Han, C; Wang, S; Wang, W; Zheng, M; Zheng, W | 1 |
| Brækkan, SK; Frazer, KA; Gabrielsen, ME; Gran, OV; Hansen, JB; Hveem, K; Paulsen, B; Rosendaal, FR; Skille, H; Smith, EN | 1 |
| An, L; Lv, GY; Sun, DW | 1 |
| He, L; Hu, Q; Lavie, CJ; Liu, J; Tabung, FK; Xu, J; Zhang, Y | 1 |
| Gogos, C; Lagadinou, M; Marangos, M; Salomou, EE; Velissaris, D; Zareifopoulos, N | 1 |
| Jhang, WK; Park, SJ | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Cheng, SX; Dong, X; Hong, S; Pan, P; Song, W; Song, WF; Zhang, QL; Zhang, XZ; Zheng, DW | 1 |
| Choi, JW; Hwang, KC; Hwang, SH; Kang, JH; Kim, SW; Lee, S; Lim, S | 1 |
| Ge, Q; Li, B; Lin, Q; Liu, R; Min, Y; Shao, Y; Shi, W; Yuan, Q; Zheng, S; Zhu, P | 1 |
| Chen, Y; Cho, CH; Du, F; Li, J; Li, M; Li, X; Shen, J; Wu, X; Xiao, Z; Yu, J; Zhao, Y | 1 |
| Kieliszek, M; Lipinski, B | 1 |
| Alnor, AB; Hvas, AM; Nybo, M; Vinholt, PJ | 1 |
| Hu, XP; Qu, LD; Wang, JY; Wang, K; Zhang, GJ; Zhang, H; Zhuo, SX | 1 |
| Badri, T; Boto, A; Chen, L; Chen, Y; Datar, I; Ji, L; Melero, I; Sanmamed, MF; Schalper, K; Su, TT; Sun, J; Sznol, M; Vignali, DAA; Wang, J; Yao, S; Yin, W; Zheng, L; Zhou, T; Zhu, G; Zhu, S | 1 |
| Commerford, CD; Detmar, M; Dieterich, LC; He, Y; Hell, T; Montoya-Zegarra, JA; Noerrelykke, SF; Röcken, M; Russo, E | 1 |
| Nieswandt, B; Rayes, J; Watson, SP | 1 |
| Kwaan, HC; Lindholm, PF | 1 |
| Brenner, R; Gerber, Y; Goldenberg, I; Hasin, T; Iakobishvili, Z; Klempfner, R; Kornowski, R; Shlomo, N | 1 |
| Aburatani, H; Akashi-Takamura, S; Hiratsuka, S; Ishibashi, S; Kijima, H; Maru, Y; Miyake, K; Murakami, M; Tomita, T; Watanabe, A | 1 |
| Kremer, LC; Schoot, RA; van de Wetering, MD; van Ommen, CH | 1 |
| BALE, WF; GOODLAND, RL; SPAR, IL | 1 |
| Asanuma, K; Kamimoto, Y; Katayama, N; Matsumoto, T; Mizuno, T; Nomura, H; Ohishi, K; Saito, K; Usui, M; Wada, H; Yamada, N; Yamashita, Y | 1 |
| Frenk, SM; Li, T; Yang, YC | 1 |
| Al-Hilal, TA; Alam, F; Byun, Y; Kim, K; Kwon, IC; Park, JW; Ryu, GH | 1 |
| Kiefer, JD; Matasci, M; Neri, D; Putelli, A; Zadory, M | 1 |
| Aizezi, R; Chen, Y; Upur, H; Zhong, M | 1 |
| Costa, F; Cunha, L; Dias, A; Lencart, J; Pereira, A; Santos, L; Sarmento, S; Silva, JP; Sousa, O | 1 |
| Boltes, A; Cocho, D; Espinosa, J; Gendre, J; Jimenez, M; Otermin, P; Pons, J; Ricciardi, AC | 1 |
| Bevelacqua, V; Fenga, C; Guarneri, C; Libra, M; Malaponte, G; Polesel, J; Signorelli, SS; Taborelli, M; Umezawa, K | 1 |
| Kuhn, P; McCarty, OJ; Mitrugno, A; Tormoen, GW | 1 |
| Cohen, EE; Engelmann, J; Filipits, M; Heinze, G; Kornek, G; Nkenke, E; Perisanidis, B; Perisanidis, C; Psyrri, A; Stift, A | 1 |
| Ay, C; Kaider, A; Marosi, C; Pabinger, I; Quehenberger, P; Reitter, EM; Zielinski, C | 1 |
| Baxter, AE; Kaufmann, DE | 1 |
| Allin, KH; Bojesen, SE; Nordestgaard, BG | 1 |
| Lipinski, B | 1 |
| Allen, JD; Chen, VM; Curnow, JL; Ehteda, A; Kritharides, L; Reddel, CJ; Robertson, G; Taylor, R | 1 |
| FAVRE-GILLY, J; GONIN, A | 1 |
| Akay, OM; Canturk, Z; Gulbas, Z; Mutlu, FS; Ustuner, Z | 1 |
| Dong, X; Guo, E; Guo, Q; Huang, H; Wu, Y; Xie, Q; Zhang, B | 1 |
| Hao, S; Jiao, Y; Liu, Y; Shen, J; Wei, M; Zeng, X; Zhang, C; Zheng, S | 1 |
| Konstantopoulos, K; Thomas, SN | 1 |
| Gullett, N; Johnstone, PA; Kucuk, O; Rossi, P | 1 |
| Collins, R; Danesh, J; Di Angelantonio, E; Kaptoge, S; Lowe, G; Pepys, MB; Thompson, SG | 1 |
| De Stavola, BL; dos Santos Silva, I; Meade, TW; Pizzi, C | 1 |
| Jensen, AL; Jessen, LR; Kjelgaard-Hansen, M; Kristensen, AT; Rozanski, E; Wiinberg, B | 1 |
| Chen, H; Li, D; Wang, H; Yuan, L; Zhou, F | 1 |
| Couto, G; Lara García, A; Vilar Saavedra, P; Zaldívar López, S | 1 |
| Ay, C; Dunkler, D; Horvath, B; Mannhalter, C; Pabinger, I; Pabinger, M; Quehenberger, P; Tiedje, V; Zielinski, C | 1 |
| Akassoglou, K; Davalos, D | 1 |
| Ashitate, Y; Bae, S; Choi, HS; Frangioni, JV; Gibbs, SL; Henary, M; Hyun, H; Kim, SH; Lee, JH; Liu, F; Park, G; Xie, Y | 1 |
| Bachmann, E; Schardt, FW; Schmausser, B | 1 |
| Bayer, E; Gelbmann, D; Gerner, C; Peter, B; Posovszky, C; Schulte-Hermann, R; Vejda, S; Zelzer, S | 1 |
| De Staercke, C; Hooper, WC | 1 |
| Gabazza, EC; Kushiya, F; Mori, Y; Nishikawa, M; Nobori, T; Okabayashi, K; Shiku, H; Wada, H; Watanabe, M | 1 |
| Clanton, J; Donnelly, E; Gao, X; Geng, L; Giorgio, T; Hallahan, D; Qu, S; Scarfone, C | 1 |
| Degen, JL; La Jeunesse, CM; Liu, H; Palumbo, JS; Talmage, KE; Witte, DP | 1 |
| IWATSURU, R; KATO, I; YUTANI, I | 1 |
| VERNONI, G | 1 |
| GUEST, MM | 1 |
| CRANE, JJ; HAMILTON, J; WARE, AG | 2 |
| FRICK, PG | 1 |
| FURUE, H; SAKAI, K; TAZAKI, Y | 1 |
| FRIEDRICH, M; KOPPERMANN, E; PETRAN, K | 1 |
| MASETTO, I | 1 |
| DAY, ED; PLANINSEK, JA; PRESSMAN, D | 2 |
| AGEE, J; PARSONS, J; WYCOFF, HD | 1 |
| BERTONI, L; DAZZI, L | 1 |
| BRAUN-FALCO, F; LEICHER, H | 1 |
| BECKER, T | 1 |
| BOROS, M; KULKA, F | 1 |
| BECCHINI, MF; GIORDANI, R; RICCIONI, N | 1 |
| HOLGER-MADSEN, T; SCHIOLER, M | 1 |
| BECCHINI, MF; GIORDANI, R; MONASTERIO, G | 1 |
| BANHIDI, E; MARCZ, I; OSVATH, A | 1 |
| BALE, WF; DI CHIRO, G; GOODLAND, RL; SPAR, IL | 1 |
| ALBERS, H; SCHMIDT, F | 1 |
| GIAMMALVO, JT; KARACA, M; STEFANINI, M | 1 |
| NAKATA, Y; SAKAMOTO, Y | 1 |
| BEEHINI, MF; GIORDANI, R; GLAGNONI, P; RICCIONI, N | 1 |
| D AMBRA, L; DERENZI, G; LAMARCHE, V | 1 |
| SCHOTTEK, W | 1 |
| DESIDERIO, MA; GOODLAND, RL; SPAR, IL | 2 |
| SHAEFFER, JR | 3 |
| SHIBUSAWA, K | 1 |
| WOODS, JR | 1 |
| BENEDETTO, A; BOSSI, G; ZINA, G | 1 |
| KHRUSHCHOVA, VM | 1 |
| BAXTER, D; CARPENTER, CM; GODFREY, JF; MEYERS, RL; MILLER, JN; ROBERTS, DM; WEIMER, HE | 1 |
| GRAEBER, W | 1 |
| GREEN, JP | 1 |
| RIECHE, K | 3 |
| KUHLGATZ, G | 1 |
| MONASTERIO, G | 1 |
| STEINMANN, B | 1 |
| HIKIDA, K; HIRAMATSU, H; OBA, S; YUNOKI, M | 1 |
| SCHULZ, FH | 1 |
| ERNST, H; LISS, E; SCHMIDT, F | 1 |
| Barrett, J; Bartis, J; Bozarth, J; Edwards, S; Ellars, C; Harris, TD; Kalogeropoulos, S; Lazewatsky, J; Liu, S; Nguyen, T; Onthank, D; Robinson, S; Silva, P; Yalamanchili, P | 1 |
| Brown, NJ; Corke, KP; Lewis, CE; Rodgers, GR; Staton, CA; Tazzyman, S; Underwood, JC | 1 |
| Brown, NJ; Lewis, CE; Staton, CA | 1 |
| Chiarla, C; Giovannini, I; Giuliante, F; Nuzzo, G; Vellone, M | 1 |
| Hasegawa, A; Koie, H; Maruyama, H; Miura, T; Sakai, M; Sato, T; Shibuya, H; Takeuchi, A; Tokuriki, M; Watari, T; Yamaya, Y | 1 |
| Hakulinen, J; Junnikkala, S; Meri, S; Sorsa, T | 1 |
| Degen, JL; Flick, MJ; Jirousková, M; Kombrinck, KW; La Jeunesse, CM; Massari, JV; Palumbo, JS; Talmage, KE | 1 |
| Bhatia, SK; Fu, W; Hammer, DA; Im, JH; Kowalska, MA; Muschel, RJ; Wang, H | 1 |
| Hiura, H | 1 |
| Diamandis, EP; Ghosh, M; Magklara, A; Michael, IP; Pampalakis, G; Sotiropoulou, G; Wasney, G | 1 |
| Rubin, H | 1 |
| Chen, XL; Ding, J; Lu, DY | 1 |
| Cho, HI; Kang, SH; Kim, HK; Kim, JQ; Lee, DS; Park, S | 1 |
| Everett, CJ; Frithsen, IL; Koopman, RJ; Wells, BJ | 1 |
| Brooks, PC; Cretu, A | 1 |
| Bolayirli, M; Ilhan, M; Orhanoğlu, T; Ozaras, R; Ozgüroğlu, M; Turna, H | 1 |
| Francis, CW; Sahni, A; Sahni, SK; Simpson-Haidaris, PJ; Vaday, GG | 1 |
| Liu, H; Yu, HF; Zhao, HW | 1 |
| Dahl, M | 1 |
| Abudoureyimu, S; Aizezi, R; Jin, W; Upur, H; Zhang, HL | 1 |
| Frick, SL; Hogg, MM; Kline, JA; Mauerhan, DR | 1 |
| Bokemeyer, C; Brümmendorf, TH; Dierlamm, J; Eifrig, B; Haubold, K; Holstein, K; Langer, F; Marx, G; Spath, B; Wierecky, J | 1 |
| Bale, WF; Dewey, WC; Harper, PV; Marrack, D; McCardle, RJ; Spar, IL | 1 |
| Dyr, JE; Vorlová, Z | 1 |
| Bell, WR; Reiner, AP | 1 |
| Cartei, G; Casara, D; Costa, S | 1 |
| Due, J; Osterud, B | 1 |
| Copley, AL | 1 |
| Beyer, JH; Köstering, H; Krieger, G; Nagel, GA; Schuff-Werner, P | 1 |
| Nadiradze, ISh | 1 |
| Kapatsinskiĭ, EV | 1 |
| Stuart, J | 1 |
| Amiral, J; Fareed, J; Walenga, JM | 1 |
| Edwards, RL; Rickles, FR | 1 |
| Bruhn, HD; Zurborn, KH | 1 |
| Godal, HC; Holm, B; Kierulf, P | 1 |
| Bause, I; Kehl, A; Kneba, M; Krieger, G; Nagel, GA | 1 |
| Kam, B; Oishi, N; Oishi, S | 1 |
| Abe, T; Nakamura, H; Yoda, Y | 1 |
| Matsuda, T; Murakami, M; Yokouchi, M | 1 |
| Kato, K; Minesaki, M; Tanaka, M | 1 |
| O'Donnell, MR; Slichter, SJ; Storb, R; Weiden, PL | 2 |
| Ito, R; Statland, BE | 1 |
| Merskey, C | 1 |
| Barb, C; Cronlund, M; Edwards, RL; Rickles, FR | 1 |
| Feldman, BF; Madewall, BR; O'Neill, S | 1 |
| Edelstein, R; Israel, L; Samak, R | 1 |
| Garcia-Pardo, A; Gold, LI; Pearlstein, E | 1 |
| Holt, JA | 1 |
| Caen, JP; Wautier, JL | 1 |
| Harker, LA; Schwartz, KA; Slichter, SJ | 1 |
| Haeberli, A; Mombelli, G; Roux, A; Straub, PW | 1 |
| Alkjaersig, N; Fletcher, AP | 1 |
| Haselager, EM; Vreeken, J | 1 |
| Abe, T; Yoda, Y | 1 |
| Harris, JU; Johnson, AJ; Merskey, C; Swain, S; Wang, MT | 1 |
| Giolma, JP; Kies, MS; Posch, JJ; Rubin, RN | 1 |
| Peters, C; Ubachs, JM; van Wersch, JW | 1 |
| Francis, DA; Francis, JL; Gunathilagan, GJ | 1 |
| Fujita, M; Furue, H; Ishibashi, M; Ito, N; Yamaji, T | 1 |
| Bunce, LA; Francis, CW; Sporn, LA | 1 |
| Costantini, V; Zacharski, LR | 1 |
| Basser, RL; Begley, CG; Berndt, MC; Cebon, J; Cohen, B; Fox, RM; Green, MD; Grigg, AP; Hopkins, W; McGrath, KM; O'Byrne, J; O'Malley, CJ; Rasko, JE | 1 |
| Montes, R; Panizo, C; Páramo, JA; Rocha, E | 1 |
| Deguchi, K; Gabazza, EC; Hiyoyama, K; Kazama, M; Mori, Y; Nakasaki, T; Nisikawa, M; Sakuragawa, N; Shiku, H; Shimura, M; Takagi, M; Wada, H | 1 |
| Eguchi, Y; Inuzuka, K; Itoh, Y; Kohno, I; Matsuda, M; Murayama, H; Nakahara, K; Sakata, Y; Soe, G; Sugo, T | 1 |
| Mosesson, MW | 1 |
| Ensinger, C; Gerner, C; Grimm, R; Gsur, A; Holzmann, K; Obrist, P; Sauermann, G; Steinkellner, W | 1 |
| Chen, R; Curb, JD; Grove, JS; Rodriguez, BL; Tracy, RP; Yano, K | 1 |
| McMillan, D; Sattar, N | 1 |
| Rybarczyk, B; Simpson-Haidaris, PJ | 1 |
| Hanrahan, LR; Nguyen, NP; Sallah, S; Sigounas, G; Wan, JY | 1 |
| Chakravarthy, A; Cmelak, A; Geng, L; Giorgio, T; Hallahan, DE; Martin, W; Qu, S; Scarfone, C | 1 |
| Liu, X; Sun, W; Wan, W; Wang, S; Wu, Z | 1 |
| Chien, S; Gump, FE; Kinney, JM; Scholz, P; Tietjen, GW | 1 |
| Alkjaersig, NK; Fletcher, AP; O'Brien, JR; Tulevski, V | 1 |
| DeNardo, GL; DeNardo, SJ; Krohn, KA | 1 |
| Ambrosetti, A; Molino, AM; Pizzolo, G; Savarin, T; Todeschini, G; Vettore, L | 1 |
| Alvarez-Cervera, J; Lopez-Majano, V | 1 |
| Ambrus, CM; Ambrus, JL; Bross, I; Pickern, J; Soldes, S | 1 |
| Glück, D; Heyes, H | 1 |
| Boneu-Valmalette, A; Bugat, R; Combes, PF; David, JF | 1 |
| Durnov, LA; Kirdan, GV; Lorie, IuI | 1 |
| Colvin, RB; Gardner, PI; Lanigan, JM; Mosesson, MW; Roblin, RO; Verderber, EL | 1 |
| Franks, JJ; Gordon, SG; Lewis, B | 1 |
| Morikawa, M; Shimano, N; Uete, T | 1 |
| Cotton, TL | 1 |
| Chekhova, EI; Nodel'son, SE; Shitikov, BD | 1 |
| Allison, AC | 1 |
| Fidler, IJ; Gersten, DM; Hart, IR | 1 |
| Juhl, F; Permin, H; Wiik, A | 1 |
| Gervin, AS; Keown, K; Malone, JM; Moore, WS | 1 |
| Aleksandrov, NN; Chekhova, EI; Filatovich, LN; Nodel'son, SE; Shitikov, BD | 1 |
| Gasparini Casari, M; Marsiai, M; Noera, G; Palmieri, B | 1 |
| Datta-Gupta, N; Musser, DA; Wagner, JM; Weber, FJ | 1 |
| Hofmann, V; Mombelli, G; Roux, A; Straub, PW | 1 |
| Bettigole, RE; Murawski, GF; Robson, EB | 1 |
| Lisetskiĭ, VA; Litvin, ME; Rybchenko, VA; Shemchuk, AS | 1 |
| Ambrus, JL; Bettigole, RE; Lyman, GH; Robson, E; Urban, H | 1 |
| Dowdle, E; Wilson, EL | 1 |
| Henderson, JT; Jones, DR; Prescott, RJ; Ruckley, CV; Vasilescu, C | 1 |
| Kirdan, GV | 2 |
| Gastpar, H | 1 |
| Bergut, FA | 1 |
| Izuchi, Y; Kusunose, K; Miyanishi, E; Yamada, S | 2 |
| Forsberg, K; Törngren, S | 1 |
| Abate, NH; Carreras, LO; Fustinoni, O; Martínez Canaveri, AA; Taffuni de De Nigris, M | 1 |
| Dube, B; Khanna, MS; Kulkarni, BJ | 1 |
| Gurewich, V; Hoffmann, KD; Lipinska, I; Lipinski, B | 1 |
| Dintenfass, L; Forbes, CD | 2 |
| Chien, S; Gump, FE; Kinney, JM; Scholz, PM; Tietjen, GW | 1 |
| Duckert, F; Fridrich, R; Gruber, UF; Schaub, N | 1 |
| Danet, B; Guiraud, R; Serres, P; Simon, J | 1 |
| Ciavarella, N; Damato, V; Fanfani, G; Fratello, A; Macarini, N | 1 |
| Mignon, F; Morel-Maroger, L; Richet, G; Whitworth, JA | 1 |
| Kockum, C | 1 |
| Berse, B; Brown, LF; Dvorak, AM; Dvorak, HF; Nagy, JA; Senger, DR; Sioussat, TM; van de Water, L; Yeo, KT; Yeo, TK | 1 |
| Katoh, H; Ohsato, K; Okamoto, K; Takaki, A; Takeda, S | 1 |
| Kawahara, T; Kido, T; Shindoh, T; Sugitachi, A | 1 |
| Bini, A; Kudryk, BJ; Rosebrough, SF; Schaible, TF | 1 |
| Hino, F; Katayama, M; Kato, I; Kurome, T; Uchida, H; Yamamoto, K | 1 |
| Andreesen, R; Brugger, W; Engler, H; Kopf, S; Krause, S; Leser, HG; Löhr, GW; Scheibenbogen, C; Schümichen, C | 1 |
| Cheresh, DA | 1 |
| Bernier, M; Bron, D; Richard, V; Sculier, JP; Themelin, L | 1 |
| Andoh, K; Kobayashi, N; Maekawa, T; Naruse, T; Tanaka, H; Uchiyama, T | 1 |
| Kakishita, E; Nakagawa, M; Yasunaga, K | 1 |
| Gleysteen, JJ; Heckman, MG; Hussey, CV | 1 |
| Fukuroi, T; Kokawa, T; Nagata, H; Nomura, S; Soga, T; Sone, N; Yanabu, M; Yasunaga, K | 1 |
| Bona, RD; Edwards, RL; Klaus, M; Matthews, E; McCullen, C; Rickles, FR | 1 |
| Brass, B; Harsch, U; Heimpel, H; Kreuser, ED; Schreml, W; Seifried, E | 1 |
| Hlousková, D; Kase, F; Pospísil, J | 1 |
| Samori, T | 1 |
| Kobayashi, N | 1 |
| Barzegar, S; Bauer, KA; Rosenberg, RD; Sherman, ML; Spriggs, DR; ten Cate, H | 1 |
| Bachaud, M; Boneu, A; Boneu, B; Bugat, R | 1 |
| Bruhn, HD; Pheiffer, KF; Zurborn, KH | 1 |
| Chen, JM | 1 |
| Schafer, AI | 1 |
| Eisler, K; Klaubert, W; Lange, J; Wilmanns, W | 1 |
| Cochan Priollet, B; Haguenau, M; Lecoz, P; Mikol, J; Moulinier, L; Pépin, B; Soria, C; Woimant, F | 1 |
| Gonciarz, Z; Górka, Z; Kacperek, T; Lampe, P; Nowak, A; Rudnicki, M; Stadnicki, A | 1 |
| Agmon, J; Aronson, M; Berliner, S; Fuchs, J; Hazaz, B; Kariv, N; Pinkhas, J; Rotenberg, Z; Seligsohn, U; Weinberger, I | 1 |
| Haeberli, A; Mombelli, G; Monotti, R; Straub, PW | 1 |
| Cornell, CJ; Edwards, RL; Forcier, RJ; Forman, WB; Headley, E; Henderson, WG; Moritz, TE; O'Donnell, JF; Rickles, FR; Zacharski, LR | 1 |
| Carr, ME; Gabriel, DA | 1 |
| el-Far, MA; Pimstone, NR | 1 |
| Fenwick, GR; Hanley, AB | 1 |
| Dvorak, AM; Dvorak, HF; Harvey, VS; McDonagh, J; Senger, DR | 1 |
| Boiadzhiian, KhP | 1 |
| Uchida, K | 1 |
| García-Conde Bru, J; Marugán de la Concha, I; Navarro Gonzalo, I; Ruiz Guinaldo, MA | 1 |
| Clarke, MB; Howe, CT; Kakkar, VV; Nicolaides, AN; Renney, JT | 1 |
| Laki, K | 1 |
| Brown, N; Negus, D; Pinto, DJ | 1 |
| Nakagawa, Y; Shimada, N | 1 |
| Bloch, KJ; Colman, RW; Myers, AR; Niewiarowski, S; Thomas, DP | 1 |
| Johnson, AJ; Merskey, C | 1 |
| Pryce, JD | 1 |
| Komp, DM | 1 |
| Bowie, EJ; Elveback, LR; Kazmier, FJ; Owen, CA; Sun, NC | 1 |
| Bowie, EJ; Cooper, HA; Owen, CA | 1 |
| Dube, B; Khanna, MN; Kulkarni, BJ | 1 |
| Abe, M; Chikatsu, I; Iida, A; Isogai, Y; Mochizuki, K | 1 |
| Sherry, S | 1 |
| Harker, LA; Slichter, SJ | 2 |
| Guseĭnov, ChS; Petrov, LA; Rakhmaeva, VA; Vantsian, EN | 1 |
| Erödi, A | 1 |
| Mehta, A; Miller, SP; Pochedly, C | 1 |
| Cotton, LT; Roberts, VC | 1 |
| Mardiney, MR; Markham, RV; Sutherland, JC | 1 |
| Arkin, C; Smith, SB | 1 |
| Hedner, U; Nilsson, IM | 1 |
| Honma, M; Kaii, S; Kato, S; Tatsuno, I | 1 |
| Matsuda, T | 1 |
| Brugarolas, A; Elias, EG; Mink, IB; Mittelman, A | 1 |
| Lisiewicz, J; Moszczyński, P; Okulski, J; Szmigiel, Z | 1 |
| Kjartansson, I; Korsan-Bengtsen, K; Peterson, HI; Rudenstam, CM; Zettergren, L | 1 |
| Peck, SD; Reiquam, CW | 1 |
| Perron, L; Thuot, C | 1 |
| Farbiszewski, R; Glowinski, S; Rzeczycki, W; Worowski, K | 1 |
| Ballard, RM; Bradley-Watson, PJ; Johnstone, FD; Kenney, A; McCarthy, TG | 1 |
| Javid, JP; Lackner, H | 1 |
| Cardoso, MA; de Lima, JJ; Ferreira, MV; Garcia, DS | 1 |
| Brugarolas, A; Elias, EG | 1 |
| Alkjaersig, N; Etherington, M; Fletcher, A; Madgwick, T; O'Brien, JR; Tulevski, VG | 1 |
| Hampton, JW | 1 |
| Papilian, M | 1 |
| Yamamoto, M | 1 |
| Izuchi, Y; Miyanishi, E; Yamada, S | 2 |
| Nilsson, IM | 1 |
| Harkness, J | 1 |
| Niléhn, JE | 1 |
| Gmür, J; Kammermann, B; Stünzi, H | 1 |
| Hedner, U; Nilsson, M | 1 |
| Hart, HC | 1 |
| Boardman, L; Calnan, JS; Hills, NH; Jeyasingh, K; Pflug, JJ | 1 |
| Black, JM; Garvey, MB | 1 |
| Brody, JI | 1 |
| Abendroth, K; Richter, G | 1 |
| Perelli-Ercolini, M; Sforza, M | 1 |
| Iwaki, M; Takayanagi, N | 1 |
| Müller, J; Stampfer, E | 1 |
| Takaki, H | 1 |
| Kuhl, DE; Sanders, TP | 1 |
| Mammen, E; Walt, AJ; Wilson, RF | 1 |
| Sánchez Avalos, JC | 1 |
| Bowie, EJ; Didisheim, P; Oels, HC; Owen, CA; Thompson, JH | 1 |
| Hiemeyer, V; Hilgard, P | 2 |
| Karrer, K; Schneider, CC | 1 |
| Buraschi, J; Sack, ES | 1 |
| Bergut, FA; Gorodilova, VV; Saraeva, ZM | 1 |
| Götz, H; Moussazadeh, M; Reichel, H | 1 |
| Davis, RB; Kennedy, BJ; Theologides, A | 1 |
| Kosmala, U; Niewiadomska, S; Plamieniak, Z | 1 |
| Abildgaard, CF | 1 |
| Evensen, SA; Hjort, PF; Jeremic, M | 1 |
| Becchini, MI; Monasterio, G; Riccioni, N | 1 |
| Winkler, C | 1 |
| Ernst, H; Liss, E | 1 |
| Andros, G; Bale, WF; Harper, PV; Jiminez, F; McCardle, RJ; Spar, IL | 1 |
| Aloisi, M; Becchini, MF; Riccioni, N | 1 |
| Misra, UK | 1 |
61 review(s) available for fibrinogen and Benign Neoplasms
| Article | Year |
|---|---|
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target.
Topics: Animals; Antigens, CD; Epithelial-Mesenchymal Transition; Fibrinogen; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Lymphocyte Activation Gene 3 Protein; Molecular Targeted Therapy; Neoplasms; Tumor Escape | 2021 |
Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential.
Topics: Biomarkers, Tumor; Fibrinogen; Humans; Immunotherapy; Liver Diseases; Metabolic Diseases; Neoplasms | 2022 |
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.
Topics: Animals; Antigens, CD; Antineoplastic Agents, Immunological; Fibrinogen; Humans; Ligands; Neoplasms; Tumor Microenvironment | 2021 |
The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application.
Topics: Antibodies, Monoclonal; Fibrinogen; Humans; Immunotherapy; Neoplasms; Tumor Escape; Tumor Microenvironment | 2022 |
LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors.
Topics: Antibodies, Monoclonal; Fibrinogen; Humans; Lymphocyte Activation; Neoplasms; Tumor Microenvironment | 2022 |
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer.
Topics: COVID-19; COVID-19 Vaccines; Fibrinogen; Humans; Neoplasms; Pandemics; Pharmaceutical Preparations; Purpura, Thrombocytopenic, Idiopathic; SARS-CoV-2; Syndrome; Thrombocytopenia; Thrombosis; Vaccines | 2022 |
Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis.
Topics: Albumins; Biomarkers, Tumor; Fibrinogen; Humans; Neoplasms; Prealbumin; Prognosis | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis.
Topics: Disease-Free Survival; Fibrinogen; Humans; Leukocyte Count; Lymphocytes; Neoplasms; Neutrophils; Prognosis; Progression-Free Survival; Proportional Hazards Models | 2020 |
The role of Fibrinogen-like proteins in Cancer.
Topics: Animals; Fibrinogen; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasms; Signal Transduction; Tumor Microenvironment | 2021 |
Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis.
Topics: Animals; Arthritis; Cardiovascular Diseases; Diabetes Mellitus; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Diseases; Lung Diseases; Models, Biological; Neoplasms; Nervous System Diseases; Polymerization; Protein Interaction Domains and Motifs; Serum Albumin, Human; Solubility; Thrombosis | 2018 |
Functional significance of the platelet immune receptors GPVI and CLEC-2.
Topics: Amino Acid Motifs; Animals; Collagen; Extracellular Matrix; Fibrin; Fibrinogen; Humans; Inflammation; Lectins, C-Type; Membrane Glycoproteins; Neoplasm Proteins; Neoplasms; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Thrombosis | 2019 |
Fibrin and Fibrinolysis in Cancer.
Topics: Animals; Blood Platelets; Cell Movement; Fibrin; Fibrinogen; Fibrinolysis; Humans; Integrins; Neoplasms; Protein Binding | 2019 |
Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Topics: Anticoagulants; Antithrombins; Central Venous Catheters; Child; Controlled Clinical Trials as Topic; Factor VIII; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Plasma; Randomized Controlled Trials as Topic; Venous Thromboembolism; Warfarin | 2013 |
The prothrombotic activity of cancer cells in the circulation.
Topics: Anticoagulants; Antineoplastic Agents; Blood Coagulation; Blood Platelets; Factor VIIa; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplastic Cells, Circulating; Platelet Activation; Prothrombin; Thromboplastin; Thrombosis | 2016 |
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis.
Topics: Disease Progression; Disease-Free Survival; Fibrinogen; Humans; Neoplasms; Prognosis; Proportional Hazards Models | 2015 |
Redox-Active Selenium in Health and Disease: A Conceptual Review.
Topics: Animals; Bacterial Infections; Fibrinogen; Humans; Neoplasms; Oxidation-Reduction; Selenic Acid; Selenious Acid; Selenium; Virus Diseases | 2019 |
Cancer cells in transit: the vascular interactions of tumor cells.
Topics: Antineoplastic Agents; Blood Vessels; Carcinoma; Colonic Neoplasms; Fibrinogen; Humans; Hyaluronan Receptors; Integrins; Ligands; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Selectins | 2009 |
Cancer-induced cachexia: a guide for the oncologist.
Topics: Acute-Phase Reaction; Anti-Inflammatory Agents, Non-Steroidal; Appetite Stimulants; C-Reactive Protein; Cachexia; Diagnosis, Differential; Dronabinol; Fibrinogen; Humans; Lipolysis; Medical Oncology; Muscle Proteins; Neoplasms; Psychotropic Drugs; Starvation; Syndrome; Tumor Necrosis Factor-alpha | 2009 |
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Topics: Alcohol Drinking; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol; Coronary Disease; Databases, Factual; Diabetes Mellitus; Female; Fibrinogen; Humans; Interleukin-6; Leukocyte Count; Lung Diseases; Male; Middle Aged; Motor Activity; Neoplasms; Regression Analysis; Risk Assessment; Risk Factors; Serum Albumin; Sex Factors; Smoking; Stroke; Triglycerides | 2010 |
Fibrinogen as a key regulator of inflammation in disease.
Topics: Alzheimer Disease; Animals; Arthritis, Rheumatoid; Bacterial Infections; Blood Coagulation; Brain Injuries; Colitis; Fibrinogen; Humans; Inflammation; Kidney Diseases; Multiple Sclerosis; Muscular Dystrophy, Duchenne; Neoplasms; Pulmonary Fibrosis; Spinal Cord Injuries; Stroke; Thrombin; Thromboplastin; Vascular Diseases | 2012 |
Venous thromboembolism: implications for gene-based diagnosis and technology development.
Topics: Activated Protein C Resistance; Blood Proteins; Disease Susceptibility; Epistasis, Genetic; Factor V; Female; Fibrinogen; Forecasting; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Male; Molecular Diagnostic Techniques; Neoplasms; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin; Thromboembolism; Thrombophilia; Venous Thrombosis | 2002 |
The role of fibrinogen and related fragments in tumour angiogenesis and metastasis.
Topics: Animals; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Peptide Fragments | 2003 |
[Fibrinogen (factor I) and dys (functional) -fibrinogen].
Topics: Afibrinogenemia; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhagic Disorders; Humans; Liver Diseases; Neoplasms; Reference Values; Severity of Illness Index; Thrombophilia | 2004 |
Systemic effects of cancer: role of multiple proteases and their toxic peptide products.
Topics: Adipose Tissue; Animals; Cachexia; Cathepsins; Enzyme Activation; Fibrinogen; Humans; Immune Tolerance; Lipolysis; Neoplasms; Peptide Hydrolases; Peptides | 2005 |
Impact of the non-cellular tumor microenvironment on metastasis: potential therapeutic and imaging opportunities.
Topics: Animals; Cell Adhesion; Cell Communication; Cell Transformation, Neoplastic; Collagen; Epitopes; Extracellular Matrix; Fibrinogen; Humans; Laminin; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Peptides; Phenotype; Vitronectin | 2007 |
The fibrinolytic system in man.
Topics: alpha 1-Antitrypsin; alpha-2-Antiplasmin; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Arterial Occlusive Diseases; Arteriosclerosis; Complement C1 Inactivator Proteins; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; Kidney Diseases; Liver Diseases; Myocardial Infarction; Neoplasms; Plasminogen; Pulmonary Embolism; Thrombophlebitis | 1984 |
The physiological significance of the endoendothelial fibrin lining (EEFL) as the critical interface in the "vessel-blood organ' and the importance of in vivo "fibrinogenin formation' in health and disease.
Topics: Adhesiveness; Animals; Arteriosclerosis; Basement Membrane; Blood Coagulation; Blood Vessel Prosthesis; Blood Viscosity; Capillaries; Capillary Permeability; Decompression Sickness; Endothelium; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Gels; Homeostasis; Humans; Hydrogen-Ion Concentration; Neoplasms; Polysaccharides; Protein Conformation; Protein Precursors; Rheology | 1983 |
[Intravascular coagulation of blood in patients with malignant neoplasms].
Topics: Blood Platelets; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysis; Humans; Neoplasms | 1983 |
[Thrombosis in patients with malignant neoplasms (review of the literature)].
Topics: Blood Coagulation; Fibrinogen; Humans; Neoplasms; Phlebitis; Platelet Aggregation; Thromboembolism; Thromboplastin | 1983 |
The acute-phase reaction and haematological stress syndrome in vascular disease.
Topics: Arteriosclerosis; Arthritis, Rheumatoid; Bone Marrow; Diabetes Mellitus; Erythrocyte Deformability; Female; Fibrinogen; Humans; Liver; Male; Neoplasms; Pregnancy; Stress, Physiological; Syndrome; Vascular Diseases | 1984 |
Selected hemostatic abnormalities associated with neoplastic disease.
Topics: Antithrombin III; Blood Coagulation; Blood Coagulation Disorders; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Neoplasms; Plasminogen Activators; Plasminogen Inactivators | 1982 |
Fibronectin: a review of its structure and biological activity.
Topics: Amino Acid Sequence; Amino Acids; Animals; Blood Platelets; Cell Adhesion; Cell Membrane; Cell Transformation, Neoplastic; Collagen; Fibrinogen; Fibronectins; Humans; Membrane Proteins; Mononuclear Phagocyte System; Neoplasms; Protein Conformation; Wound Healing | 1980 |
[The endothelium: protective barrier or irritating thorn].
Topics: Anemia, Sickle Cell; Cell Adhesion; Cells, Cultured; Diabetes Mellitus; Endothelium; Erythrocytes; Fibrinogen; Fibronectins; Humans; Leukocytes; Neoplasms; Rheology; Thrombosis | 1982 |
Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
Topics: Amino Acid Sequence; Animals; Cell Adhesion; Endothelium, Vascular; Fibrin; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Inflammation; Macromolecular Substances; Molecular Sequence Data; Neoplasms; Platelet Adhesiveness; Thrombosis; von Willebrand Factor | 1993 |
Fibrin and cancer.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Cysteine Endopeptidases; Fibrin; Fibrinogen; Humans; Microcirculation; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Thrombin | 1993 |
Acute generalized, widespread bleeding. Diagnosis and management.
Topics: Acute Disease; Algorithms; Antibodies, Monoclonal; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Blood Coagulation Tests; Contraindications; Cytokines; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematologic Diseases; Hemorrhage; Heparin; Humans; Infections; Liver Diseases; Neoplasms; Plasma; Platelet Transfusion; Thrombophilia | 1998 |
Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein.
Topics: Animals; Extracellular Matrix Proteins; Fibrinogen; Humans; Mice; Neoplasms | 2001 |
Radiation-mediated control of drug delivery.
Topics: Animals; Antineoplastic Agents; Bacterial Proteins; Clinical Trials, Phase I as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Electromagnetic Phenomena; Fibrinogen; Genetic Therapy; Humans; Immunoconjugates; Ligands; Liposomes; Microspheres; Neoplasms; Oligopeptides; Peptide Library; Radiation-Sensitizing Agents; Radiation, Ionizing; Radioimmunotherapy; Receptors, Immunologic; Receptors, Peptide; Repressor Proteins | 2001 |
Neoplasm localization with radionuclides.
Topics: Animals; Antibodies, Neoplasm; Bleomycin; Fibrinogen; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Mercury Radioisotopes; Neoplasms; Radionuclide Imaging; Selenomethionine; Tetracycline | 1979 |
[The significance of fibrin/fibrinogen for growth and metastasis of malignant tumors (author's transl)].
Topics: Animals; Anticoagulants; Blood Platelets; Fibrin; Fibrinogen; Fibrinolysin; Humans; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Neoplastic Cells, Circulating; Urokinase-Type Plasminogen Activator | 1977 |
The prevention of deep vein thrombosis, with particular reference to mechanical methods of prevention.
Topics: Adult; Aged; Constriction; Electric Stimulation; Exercise Therapy; Fibrinogen; Heparin; Humans; Leg; Middle Aged; Neoplasms; Physical Exertion; Regional Blood Flow; Thrombophlebitis; Veins | 1977 |
Macrophage activation and nonspecific immunity.
Topics: Adjuvants, Immunologic; Animals; Antigen-Antibody Complex; Bacteriolysis; Bone Marrow Cells; Cell Differentiation; Complement System Proteins; Endotoxins; Eukaryota; Fibrinogen; Humans; Immunity, Innate; Interferon Inducers; Interferons; Lymphokines; Macrophages; Neoplasms; Phagocytosis; Plasminogen Activators; Prostaglandins; Pyrogens; T-Lymphocytes; Thromboplastin | 1978 |
The biology of cancer invasion and metastasis.
Topics: Animals; Cell Adhesion; Cell Cycle; Cell Division; Cell Membrane; Cell Movement; Cell Survival; Embolism; Fibrinogen; Glucosyltransferases; Humans; Immunity, Cellular; Inflammation; Lymph Nodes; Lymphatic Metastasis; Melanoma; Membrane Lipids; Membrane Proteins; Mice; Microcirculation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Experimental; Neoplastic Cells, Circulating; Platelet Aggregation; Surface Properties; Thoracic Duct | 1978 |
[Malignant neoplasms and thromboses].
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhagic Disorders; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Thromboembolism | 1976 |
[Changes in the blood coagulation system and fibrinolysis during growth and metastasis of malignant neoplasms].
Topics: Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Neoplasm Metastasis; Neoplasms; Thromboplastin; Thrombosis | 1976 |
[Determination of fibrinogen].
Topics: Adult; Afibrinogenemia; Aged; Cerebrovascular Disorders; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms | 1976 |
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
Topics: Blood Coagulation; Capillary Permeability; Endothelial Growth Factors; Fibrin; Fibrinogen; Humans; Kinetics; Lymphokines; Microcirculation; Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1992 |
Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Arteriosclerosis; Dogs; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Kidney Diseases; Neoplasms; Pregnancy; Pregnancy Complications; Radioimmunodetection; Thrombosis | 1991 |
Integrins in thrombosis, wound healing and cancer.
Topics: Amino Acid Sequence; Fibrinogen; Humans; Integrins; Molecular Sequence Data; Neoplasms; Platelet Membrane Glycoproteins; Thrombosis; Wound Healing | 1991 |
[Hemostatic mechanisms and malignant tumors].
Topics: Animals; Blood Coagulation Factors; Blood Platelets; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Fibrinopeptide B; Humans; Neoplasms; Neoplastic Cells, Circulating; Plasminogen Activators; Platelet Aggregation; Thromboembolism | 1985 |
The hypercoagulable states.
Topics: Antithrombin III Deficiency; Arterial Occlusive Diseases; Biocompatible Materials; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Viscosity; Contraceptives, Oral; Diabetes Complications; Factor XII Deficiency; Female; Fibrinogen; Fibrinolysis; Glycoproteins; Hemoglobinuria, Paroxysmal; Homocystinuria; Humans; Hyperlipidemias; Lupus Coagulation Inhibitor; Myeloproliferative Disorders; Neoplasms; Nephrotic Syndrome; Pregnancy; Pregnancy Complications, Hematologic; Protein C; Protein S; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Thrombocytosis; Thromboembolism; Vasculitis; Venous Insufficiency | 1985 |
The genus Allium--Part 3.
Topics: Allium; Animals; Arteriosclerosis; Asthma; Bacteria; Blood Glucose; Blood Protein Electrophoresis; Cholesterol; Clofibrate; Coronary Disease; Dermatitis, Contact; Dietary Fats; Drug Interactions; Fibrinogen; Fibrinolysis; Fungi; Garlic; Humans; Hyperlipidemias; Insecta; Microbial Sensitivity Tests; Mutagenicity Tests; Neoplasms; Oils, Volatile; Patch Tests; Plant Extracts; Plants, Medicinal; Platelet Aggregation; Prothrombin Time; Rabbits; Whole Blood Coagulation Time | 1985 |
[Hemostatic system in cancer patients].
Topics: Animals; Blood Coagulation; Fibrinogen; Fibrinolysis; Humans; Male; Neoplasms; Pancreatic Neoplasms; Platelet Adhesiveness; Prostatic Neoplasms; Rats; Stomach Neoplasms | 1972 |
[Magnesium--an anticoagulant physiological electrolyte].
Topics: Adenosine Triphosphate; Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Blood Pressure; Calcium; Cholesterol; Enzyme Activation; Erythrocytes; Female; Fibrinogen; Heart; Humans; Immunity; Lipid Metabolism; Magnesium; Muscle, Smooth; Neoplasms; Phagocytosis; Pregnancy; Rats; Stress, Physiological; Thromboembolism | 1973 |
[Fibrinogen--interpretation of the test results].
Topics: Afibrinogenemia; Cerebrovascular Disorders; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Inflammation; Methods; Neoplasms | 1973 |
[Disseminated intravascular coagulation].
Topics: Animals; Blood Coagulation Disorders; Blood Platelet Disorders; Fibrinogen; Fibrinolysis; Humans; Lymphatic Diseases; Neoplasms; Vasomotor System | 1969 |
[Cancer chemotherapy and blood coagulation-fibrinolysis system].
Topics: Adult; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Factors; Breast Neoplasms; Dextrans; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Rectal Neoplasms; Sulfates | 1971 |
[Fibrinogen--how to read its figures].
Topics: Afibrinogenemia; Cerebral Arterial Diseases; Coronary Disease; Female; Fibrinogen; Humans; Male; Methods; Neoplasms | 1971 |
The viscosity of human blood plasma; its measurement in health and disease.
Topics: Acute Disease; Adult; Age Factors; Anticoagulants; Blood Protein Disorders; Blood Proteins; Blood Viscosity; Chronic Disease; Circadian Rhythm; Diagnosis; Female; Fibrinogen; Humans; Infant, Newborn; Male; Methods; Neoplasms; Physical Exertion; Plasma; Pregnancy; Rheology; Serum Albumin; Serum Globulins; Sex Factors; Temperature | 1971 |
[Fibrinogen: interpretation of the test results].
Topics: Afibrinogenemia; Cerebrovascular Disorders; Female; Fibrinogen; Humans; Male; Methods; Neoplasms | 1969 |
8 trial(s) available for fibrinogen and Benign Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Hypercoagulability in cancer patients grouped by syndromes differentiated with the theory of abnormal hilit in traditional Uyghur medicine.
Topics: Adult; Blood Coagulation; Diagnosis, Differential; Female; Fibrinogen; Humans; Male; Medicine, Chinese Traditional; Neoplasms; Platelet Count; Prothrombin Time; Thrombophilia; Young Adult | 2014 |
Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation.
Topics: Cohort Studies; Fibrinogen; Humans; Neoplasms; P-Selectin; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Polyethylene Glycols; Recombinant Proteins; Thrombopoietin | 1996 |
[Incidence of postoperative deep vein thrombosis in general surgical and urological patients an investigation by means of the 125I-Fibrinogen test in 95 patients withoug prophylaxis (author's transl)].
Topics: Adult; Age Factors; Aged; Colon; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Postoperative Complications; Sex Factors; Surgical Procedures, Operative; Thrombophlebitis | 1975 |
A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes.
Topics: Biopterins; Cell Movement; Cells, Cultured; Cytapheresis; Fibrin; Fibrinogen; Humans; Immunotherapy, Adoptive; Interferon-gamma; Macrophage Activation; Macrophages; Monocytes; Neoplasms; Neopterin; Pilot Projects; Recombinant Proteins; Transplantation, Autologous | 1991 |
[Study on effects of cefminox sodium on blood coagulation system].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Blood Coagulation; Cephamycins; Chi-Square Distribution; Female; Fibrinogen; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Neoplasms; Partial Thromboplastin Time; Prothrombin Time | 1990 |
Prevention of postoperative deep vein thrombosis in patients with malignant disease.
Topics: Clinical Trials as Topic; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Monitoring, Physiologic; Neoplasms; Postoperative Complications; Pressure; Thrombophlebitis; Time Factors | 1974 |
Platelet function studies before and after operation and the effect of postoperative thrombosis.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Cell Count; Blood Platelets; Chromatography; Collagen; Epinephrine; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Neoplasms; Placebos; Platelet Adhesiveness; Postoperative Complications; Radionuclide Imaging; Surgical Procedures, Operative; Thrombin; Thrombosis | 1974 |
281 other study(ies) available for fibrinogen and Benign Neoplasms
| Article | Year |
|---|---|
Study of the interaction of folic acid-modified gold nanorods and fibrinogen through microfluidics: implications for protein adsorption, incorporation and viability of cancer cells.
Topics: Adsorption; Fibrinogen; Folic Acid; Gold; Metal Nanoparticles; Microfluidics; Nanotubes; Neoplasms; Polyethylene Glycols | 2021 |
Perioperative Coagulation Profile in Major Liver Resection for Cancer: A Prospective Observational Study.
Topics: Anticoagulants; Antithrombins; Blood Coagulation Factors; Blood Coagulation Tests; Fibrinogen; Hepatectomy; Humans; Liver; Neoplasms; Protein C; Thrombin; Venous Thromboembolism; von Willebrand Factor | 2022 |
Evaluation of coated platelets, a subset of highly procoagulant platelets, in healthy dogs and dogs with neoplasia.
Topics: Animals; Blood Platelets; Dog Diseases; Dogs; Fibrinogen; Neoplasms; Platelet Activation; Thrombin | 2022 |
Crosstalk between hemostasis and immunity in cancer pathogenesis.
Topics: Carcinogenesis; Fibrinogen; Hemostasis; Hemostatics; Humans; Neoplasms; Receptor, PAR-1 | 2022 |
Automatic Evaluation for Bioengineering of Human Artificial Ovary: A Model for Fertility Preservation for Prepubertal Female Patients with a Malignant Tumor.
Topics: Bioengineering; Female; Fertility Preservation; Fibrin; Fibrinogen; Humans; Neoplasms; Ovary; Thrombin | 2022 |
Impact of Fibrinogen, Fibrin Thrombi, and Thrombin on Cancer Cell Extravasation Using In Vitro Microvascular Networks.
Topics: Animals; Blood Coagulation; Fibrin; Fibrinogen; Hemostatics; Humans; Neoplasms; Thrombin; Thrombosis | 2023 |
Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling.
Topics: Cell Line, Tumor; Extracellular Matrix; Fibrinogen; Integrins; Neoplasms; Signal Transduction | 2023 |
Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells.
Topics: Animals; Cholesterol; Fibrinogen; Immunosuppression Therapy; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Neoplasms | 2023 |
Study on the Effect of Ginsenosides Rb on Blood of Tumor Mice.
Topics: Anemia; Animals; Blood; Blood Platelets; Cell Line, Tumor; Disease Models, Animal; Erythrocytes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Ginsenosides; Hemoglobins; Hemostatics; Mice; Neoplasms; Panax; Plant Leaves; Thrombosis | 2019 |
Fibrinogen gamma gene
Topics: Alleles; Fibrinogen; Humans; Incidence; Neoplasms; Risk Factors; Venous Thromboembolism | 2020 |
Associations of C-reactive protein and fibrinogen with mortality from all-causes, cardiovascular disease and cancer among U.S. adults.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Neoplasms; Nutrition Surveys; Proportional Hazards Models; Risk Factors | 2020 |
Prognosis of COVID-19: Changes in laboratory parameters.
Topics: Adult; Aged; beta-Thalassemia; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Coronavirus Infections; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Greece; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Prognosis; Retrospective Studies; Risk Factors | 2020 |
Evaluation of Disseminated Intravascular Coagulation in Critically Ill Pediatric Hemato-oncology Patients with Septic Shock.
Topics: Adolescent; Child; Critical Illness; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Diseases; Hospital Mortality; Humans; Intensive Care Units, Pediatric; Male; Neoplasms; Platelet Count; Prothrombin Time; Retrospective Studies; Severity of Illness Index; Shock, Septic; Tertiary Care Centers | 2020 |
Controllable gelation of artificial extracellular matrix for altering mass transport and improving cancer therapies.
Topics: Animals; Biological Transport; Biomimetic Materials; Cell Line, Tumor; Cell Proliferation; Chemoradiotherapy; Disease Models, Animal; Extracellular Matrix; Female; Fibrinogen; Gels; Humans; Injections, Intravenous; Metabolomics; Mice; Neoplasms; Thrombin; Ultrasonic Therapy; Ultrasonic Waves | 2020 |
Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer Effectors.
Topics: Actins; Animals; Antibodies, Neutralizing; Cell Line, Tumor; Cell Survival; Culture Media; Electrophoresis, Gel, Two-Dimensional; Exosomes; Extracellular Vesicles; Fas Ligand Protein; Fibrinogen; Flow Cytometry; Hep G2 Cells; Humans; Immunotherapy; Killer Cells, Natural; Lymphocytes; MCF-7 Cells; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Proteome; Proteomics; Silver Staining | 2020 |
The primary haemostasis is more preserved in thrombocytopenic patients with liver cirrhosis than cancer.
Topics: Adult; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Neoplasms; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Thrombin; Thrombocytopenia | 2018 |
D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Topics: Aged; Biomarkers; Brain; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Stroke | 2018 |
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.
Topics: Animals; Antigens, CD; Cell Line; Fibrinogen; Genes, MHC Class II; Histocompatibility Antigens Class II; Humans; Immunotherapy; Ligands; Liver; Lymphocyte Activation; Lymphocyte Activation Gene 3 Protein; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Proteins; Neoplasms; T-Lymphocytes, Cytotoxic | 2019 |
Mechanisms of Tumor-Induced Lymphovascular Niche Formation in Draining Lymph Nodes.
Topics: Animals; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Female; Fibrinogen; Gene Expression Regulation, Neoplastic; Lymph Nodes; Lymphatic Metastasis; Lymphatic Vessels; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Neovascularization, Physiologic; Platelet Membrane Glycoprotein IIb; Up-Regulation | 2018 |
Association of Bezafibrate Treatment With Reduced Risk of Cancer in Patients With Coronary Artery Disease.
Topics: Bezafibrate; Cholesterol, HDL; Coronary Artery Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Israel; Lipids; Male; Middle Aged; Neoplasms; Registries; Risk Reduction Behavior; Triglycerides | 2019 |
Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci.
Topics: Animals; Capillary Permeability; Cell Line, Tumor; Chemokine CCL2; Endothelial Cells; Fibrinogen; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunity, Innate; Inflammation Mediators; Leukocytes; Lung; Lymphocyte Antigen 96; Mice; Neoplasm Metastasis; Neoplasms; Organ Culture Techniques; Receptors, CCR2; S100 Proteins; Serum Amyloid A Protein; Signal Transduction; Toll-Like Receptor 4 | 2013 |
Research directed toward the use of I-131 labeled fibrinogen and antibody to fibrin in the localization and treatment of tumors.
Topics: Antibodies; Fibrin; Fibrinogen; Humans; Immunoglobulins; Iodine; Iodine Isotopes; Neoplasms | 1962 |
Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism.
Topics: Adult; Aged; Biomarkers, Tumor; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; ROC Curve; Venous Thromboembolism | 2014 |
Social network ties and inflammation in U.S. adults with cancer.
Topics: C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Neoplasms; Nutrition Surveys; Risk Factors; Serum Albumin; Social Isolation; Social Support; United States | 2014 |
Prevention effect of orally active heparin conjugate on cancer-associated thrombosis.
Topics: Administration, Oral; Animals; Anticoagulants; Deoxycholic Acid; Factor Xa; Fibrinogen; Heparin Antagonists; Heparin, Low-Molecular-Weight; Humans; Hyperthermia, Induced; Male; Mice, Inbred ICR; Neoplasms; Protamines; Rats, Sprague-Dawley; Thrombosis | 2014 |
A fibrin-specific monoclonal antibody from a designed phage display library inhibits clot formation and localizes to tumors in vivo.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Blood Coagulation; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Immunoglobulin G; Mice; Molecular Sequence Data; Mutation; Neoplasm Transplantation; Neoplasms; Peptide Library; Protein Binding; Protein Structure, Tertiary; Sequence Homology, Amino Acid; Surface Plasmon Resonance; Thrombosis | 2014 |
Attenuation measurements show that the presence of a TachoSil surgical patch will not compromise target irradiation in intra-operative electron radiation therapy or high-dose-rate brachytherapy.
Topics: Brachytherapy; Drug Combinations; Electrons; Fibrinogen; Humans; Intraoperative Care; Iridium Radioisotopes; Neoplasms; Particle Accelerators; Phantoms, Imaging; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, High-Energy; Surgical Sponges; Thrombin; Tomography, X-Ray Computed | 2015 |
Predictors of occult cancer in acute ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Stroke | 2015 |
Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis.
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Interleukin-1beta; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; Monocytes; Neoplasms; NF-kappa B; Smoking; Thromboplastin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Venous Thrombosis | 2015 |
Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasms; P-Selectin; Peptide Fragments; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prothrombin; Risk Assessment; Risk Factors; Thrombin; Time Factors; Treatment Outcome; Venous Thromboembolism; Young Adult | 2016 |
Tumor-necrosis factor is a master of T cell exhaustion.
Topics: CD8-Positive T-Lymphocytes; Fibrinogen; Humans; Neoplasms; Tumor Necrosis Factor-alpha | 2016 |
Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population.
Topics: Aged; Biomarkers, Tumor; C-Reactive Protein; Cohort Studies; Denmark; Female; Fibrinogen; Humans; Incidence; Inflammation; Leukocyte Count; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Risk | 2016 |
Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent.
Topics: Animals; Blood Coagulation; Cachexia; Cell Line, Tumor; Disease Models, Animal; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Interleukin-6; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms; Thrombin; Tissue Array Analysis | 2017 |
A case of fatal acute purpura with afibrinemia responsible for a double bleeding and coagulation disorder during latent gastric cancer.
Topics: Afibrinogenemia; Fibrinogen; Humans; Neoplasms; Purpura; Stomach Neoplasms | 1948 |
Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography.
Topics: Analysis of Variance; Blood Coagulation Tests; Female; Fibrinogen; Humans; Male; Neoplasms; Platelet Count; ROC Curve; Statistics, Nonparametric; Thrombelastography; Thrombophilia | 2009 |
Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Pancreatic Neoplasms; Predictive Value of Tests; Retrospective Studies; Young Adult | 2009 |
Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity.
Topics: Animals; Blood Platelets; Cell Adhesion; Cell Line; Cell Line, Tumor; Fibrinogen; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Neoplasms; Thrombin | 2009 |
Circulating levels of coagulation and inflammation markers and cancer risks: individual participant analysis of data from three long-term cohorts.
Topics: C-Reactive Protein; Cohort Studies; Confounding Factors, Epidemiologic; Factor VIIa; Fibrinogen; Humans; Incidence; Leukocyte Count; Lung Neoplasms; Male; Neoplasms; Peptide Fragments; Prothrombin; Smoking; United Kingdom | 2010 |
Thrombin-activatable fibrinolysis inhibitor activity in healthy and diseased dogs.
Topics: Animals; Carboxypeptidase B2; Dog Diseases; Dogs; Female; Fibrinogen; Male; Neoplasms; Partial Thromboplastin Time; Prothrombin Time; Sepsis; Systemic Inflammatory Response Syndrome | 2010 |
Gold nanoparticle layer: a promising platform for ultra-sensitive cancer detection.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Gold; Humans; Metal Nanoparticles; Muramidase; Neoplasms; Serum Albumin | 2011 |
Hemostatic abnormalities in dogs with carcinoma: a thromboelastographic characterization of hypercoagulability.
Topics: Animals; Antithrombin III; Case-Control Studies; Dog Diseases; Dogs; Female; Fibrinogen; Hemostasis; Hemostatic Disorders; Male; Neoplasms; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Thrombelastography; Thrombophilia | 2011 |
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Topics: Aged; Analysis of Variance; Austria; Biomarkers; Blood Coagulation; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms; Phenotype; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Venous Thromboembolism | 2011 |
Targeted zwitterionic near-infrared fluorophores for improved optical imaging.
Topics: Animals; Antibodies; Cell Line, Tumor; Fibrinogen; Fluorescent Dyes; Humans; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Optical Imaging; Peptides, Cyclic; Quaternary Ammonium Compounds; Signal-To-Noise Ratio; Sulfonic Acids; Surgery, Computer-Assisted | 2013 |
Monoclonal antibodies for immunodectection of fibrin deposits on cancer cells.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Epitopes; Extracellular Matrix; Female; Fibrin; Fibrinogen; Fibrinolysis; Gene Expression Regulation, Neoplastic; Humans; Immune System; Immunohistochemistry; Male; Neoplasm Metastasis; Neoplasms; Peptides | 2013 |
Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis.
Topics: alpha-2-Antiplasmin; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 8; Caspase 9; Caspases; Dimerization; Electrophoresis, Polyacrylamide Gel; fas Receptor; Female; Fibrinogen; Humans; Jurkat Cells; Laminin; Lung Neoplasms; Male; Mass Spectrometry; Neoplasms; Precipitin Tests; Prostatic Neoplasms; Signal Transduction; Ultraviolet Rays | 2002 |
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematologic Neoplasms; Hemorrhage; Humans; Infections; Interleukin-1; Interleukin-6; International Normalized Ratio; Male; Middle Aged; Multiple Organ Failure; Neoplasms; Peptide Hydrolases; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Count; Prognosis; Thrombomodulin; Thromboplastin; Thrombosis; Tissue Plasminogen Activator | 2003 |
Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels.
Topics: Albumins; Animals; Antigens, Neoplasm; Bacteriophage T7; Drug Carriers; Drug Delivery Systems; Fibrinogen; Glioma; Integrins; Iodine Radioisotopes; Liposomes; Melanoma; Mice; Nanotechnology; Neoplasm Transplantation; Neoplasms; Peptides; Radioimmunotherapy; Regional Blood Flow; Tumor Cells, Cultured; Ultrasonography, Doppler | 2003 |
Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Fibrinogen; Fibrosarcoma; Genotype; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron; Mitosis; Neoplasm Transplantation; Neoplasms; Plasminogen; Time Factors; Vascular Patency | 2003 |
Fourth report on the K.I.K. reaction: further studies on the property of K.I.K. factor in the stomach juice from stomach cancer patients.
Topics: Fibrinogen; Gastric Juice; Humans; Neoplasms; Research; Stomach Neoplasms | 1953 |
[Pathogenesis of tumors. I. Factors of normal and tumorous cell multiplication].
Topics: Cell Proliferation; Fibrinogen; Humans; Neoplasms | 1954 |
Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject.
Topics: Antifibrinolytic Agents; Body Fluids; Enzyme Precursors; Female; Fibrin; Fibrinogen; Fibrinolysin; Hematologic Diseases; Humans; Neoplasms; Plasminogen; Pregnancy; Thrombolytic Therapy; Urine | 1954 |
Spontaneous afibrinogenemia in cancer of prostate: report of two cases.
Topics: Afibrinogenemia; Fibrinogen; Hemorrhagic Disorders; Humans; Male; Neoplasms; Prostatic Neoplasms | 1954 |
Spontaneous afibrinogenemia in cancer of prostate; report of two cases.
Topics: Afibrinogenemia; Fibrinogen; Hemorrhagic Disorders; Humans; Male; Neoplasms; Prostatic Neoplasms | 1955 |
Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer.
Topics: Afibrinogenemia; Fibrinogen; Hemorrhagic Disorders; Humans; Male; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Stomach; Stomach Neoplasms | 1956 |
[Cancer and fibrinogen. I].
Topics: Coagulants; Fibrinogen; Hematologic Diseases; Humans; Neoplasms | 1956 |
[New diagnostic examinations by the Bolen blood coagulation test and its dependence on the fibrinogen level of the blood plasma].
Topics: Blood Coagulation Tests; Coagulants; Fibrinogen; Humans; Neoplasms; Plasma | 1958 |
[Possibility of differentiation of development of cirrhosis and neoplasms in ascitic fluid through determination of certain blood coagulation factors in ascitic fluid].
Topics: Ascites; Ascitic Fluid; Blood Coagulation Factors; Diagnosis, Differential; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasms; Prothrombin Time | 1958 |
Localization in vivo of radio-iodinated anti-rat-fibrin antibodies and radio-iodinated rat fibrinogen in the Murphy rat lymphosarcoma and in other transplantable rat tumors.
Topics: Animals; Fibrin; Fibrinogen; Lymphoma, Non-Hodgkin; Neoplasm Transplantation; Neoplasms; Rats | 1959 |
Elevation of plasma fibrinogen following lymphosarcoma tissue injections in rats.
Topics: Animals; Coagulants; Fibrinogen; Hemostatics; Lymphoma, Non-Hodgkin; Neoplasms; Plasma; Rats | 1959 |
[Fibrinogenemia in malignant tumors].
Topics: Coagulants; Fibrinogen; Hematologic Diseases; Hemostatics; Humans; Neoplasms | 1959 |
[Blood fibrinogen content and blood sedimentation rate in malignant tumors in the ear, nose and throat area].
Topics: Blood Sedimentation; Ear Neoplasms; Fibrinogen; Neoplasms; Nose; Nose Neoplasms; Pharynx | 1959 |
[Serum fibrinogen and tumor volume].
Topics: Fibrinogen; Hemostatics; Humans; Lymphatic Diseases; Neoplasms; Tumor Burden | 1960 |
Localization of radioiodinated rat fibrinogen in transplanted rat tumors.
Topics: Animals; Fibrinogen; Neoplasm Transplantation; Neoplasms; Rats | 1959 |
[Fibrinogen level in the blood and its evaluation in surgical pulmonary diseases with special reference to bronchial cancer].
Topics: Bronchi; Fibrinogen; Humans; Lung Abscess; Lung Diseases; Neoplasms | 1961 |
[Fixation by tumors of fibrinogen labeled with I-131].
Topics: Coagulants; Fibrinogen; Hemostatics; Humans; Neoplasms; Radioisotopes | 1962 |
Heparin resistance (measured by the heparin thrombin time) and plasma fibrinogen in various diseases.
Topics: Arteriosclerosis; Coagulants; Fibrinogen; Heparin; Humans; Neoplasms; Plasma; Thrombin; Thrombin Time; Thromboembolism | 1962 |
[New methodological trends in the diagnosis of tumors with radioisotopes].
Topics: Autoradiography; Coagulants; Fibrinogen; Hemostatics; Iodine Isotopes; Neoplasms; Povidone; Radioisotopes; Serum Albumin; Serum Albumin, Radio-Iodinated | 1963 |
[On remote biochemical effects of different lung diseases with reference to the differential diagnosis of tumors].
Topics: Bronchial Neoplasms; Diagnosis, Differential; Fibrinogen; Hemostatics; Hexosamines; Humans; Lung Diseases; Neoplasms | 1963 |
Preparation of purified I-131 labeled antisera to human fibrinogen. Preliminary studies in tumor patients.
Topics: Antibodies; Coagulants; Fibrinogen; Humans; Immune Sera; Iodine; Iodine Isotopes; Neoplasms; Neoplasms, Experimental | 1963 |
[ON THE FIBRINOGEN CONTENT OF THE PLASMA OF TUMOR-BEARING AND NORMAL RATS].
Topics: Animals; Blood Chemical Analysis; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Fibrinogen; Liver Neoplasms; Neoplasms; Rats; Research; Sarcoma, Experimental; Sarcoma, Yoshida | 1963 |
DEMONSTRATION OF TWO ADDITIONAL MECHANISMS IN THE PATHOGENESIS OF THE SYNDROME OF ACQUIRED FIBRINOGENOPENIA.
Topics: Afibrinogenemia; Blood Chemical Analysis; Blood Coagulation Tests; Carcinoma, Bronchogenic; Coagulants; Female; Fetal Death; Fibrinogen; Humans; Injections, Intravenous; Liver Function Tests; Neoplasm Metastasis; Neoplasms; Pathology; Pregnancy; Pregnancy Complications | 1963 |
[BIOCHEMICAL STUDIES ON PROTEIN METABOLISM IN THE TUMOR-BEARING ORGANISM].
Topics: Blood Chemical Analysis; Blood Protein Electrophoresis; Coagulants; Enzymes; Fibrinogen; gamma-Globulins; Humans; Neoplasms; Nitrogen; Proteins; Serum Albumin; Serum Globulins | 1963 |
[THE USE OF FIBRINOGEN-I 131 IN THE DIAGNOSIS OF TUMORS IN MAN].
Topics: Aminocaproates; Aminocaproic Acid; Fibrinogen; Humans; Iodine; Iodine Isotopes; Male; Neoplasms; Radioisotopes; Radionuclide Imaging | 1963 |
[FIXATION OF RADIOACTIVE TRACERS IN RAT CHLOROMYELOMA STUDIES IN VIVO].
Topics: Fibrinogen; Fluoresceins; Iodine Isotopes; Leukemia; Neoplasms; Neoplasms, Experimental; Povidone; Radioactive Tracers; Radiometry; Rats; Research; Serum Albumin; Serum Albumin, Radio-Iodinated | 1963 |
[FIBRINOGEN AND BRONCHIAL CARCINOMA].
Topics: Bronchial Neoplasms; Bronchitis; Carcinoma, Bronchogenic; Diagnosis, Differential; Fibrinogen; Humans; Lung Diseases; Neoplasms; Pulmonary Emphysema; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
IMMUNOLOGICAL REMOVAL OF CIRCULATING I-131-LABELED RABBIT ANTIBODY TO RAT FIBRINOGEN IN NORMAL AND TUMOR-BEARING RATS. UR-634.
Topics: Animals; Antigen-Antibody Reactions; Fibrinogen; Goats; Immune Sera; Iodine; Iodine Isotopes; Lagomorpha; Neoplasms; Neoplasms, Experimental; Rabbits; Radioisotopes; Rats; Research | 1963 |
PARTICIPATION OF THE COAGULATION MECHANISM IN TUMOR LOCALIZATION OF I-131-LABELLED FIBRINOGEN. UR-630.
Topics: Blood Coagulation; Coagulants; Fibrinogen; Heparin; Iodine Isotopes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Experimental; Pharmacology; Rats; Research; Warfarin | 1963 |
[ON AUTOIMMUNIZATION. II. ABNORMAL PLASMA PROTEINS IN CANCER PATIENTS].
Topics: Blood Protein Disorders; Blood Protein Electrophoresis; Blood Proteins; Cryoglobulins; Fibrinogen; Humans; Neoplasms; Waldenstrom Macroglobulinemia | 1964 |
EXPERIMENTAL STUDIES OF THE INTRAVASCULAR DISSEMINATION OF ASCITIC V2 CARCINOMA CELLS IN THE RABBIT, WITH SPECIAL REFERENCE TO FIBRINOGEN AND FIBRINOLYTIC AGENTS.
Topics: Animals; Autoradiography; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Humans; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Rabbits; Research; Thrombosis | 1964 |
[I-131 LABELED FIBRINOGEN IN THE DIAGNOSIS OF CUTANEOUS NEOPLASMS. PREVENTIVE NOTE].
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fibrinogen; Genetic Diseases, X-Linked; Hemangioma; Histiocytoma, Benign Fibrous; Humans; Iodine Isotopes; Leukemia, Hairy Cell; Lymphatic Diseases; Melanoma; Neoplasms; Radiometry; Severe Combined Immunodeficiency; Skin Neoplasms; Skin Ulcer | 1964 |
INTERFERENCE IN LOCALIZATION OF I-131 FIBRINOGEN IN RAT TUMORS BY ANTICOAGULANTS.
Topics: Anticoagulants; Blood Coagulation; Coagulants; Fibrinogen; gamma-Globulins; Heparin; Iodine Isotopes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Experimental; Pharmacology; Physiology; Rats; Research; Sodium; Warfarin | 1964 |
[COMPARATIVE STUDY OF BLOOD COAGULATION INDICES AND THE FIBRINOLYTIC ACTIVITY OF PATIENTS WITH CANCER, STOMACH AND DUODENAL ULCER BEFORE AND AFTER SURGERY].
Topics: Blood Coagulation Tests; Duodenal Ulcer; Fibrinogen; Fibrinolysis; Hemostatics; Humans; Neoplasms; Stomach Ulcer | 1964 |
THE EFFECTS OF TUMOR GROWTH, NUTRITIONAL STRESS, AND INFLAMMATION ON SERUM COMPLEMENT LEVELS IN THE RAT.
Topics: Animals; Blood Proteins; Carcinoma 256, Walker; Complement System Proteins; Fibrinogen; Inflammation; Neoplasms; Protein Deficiency; Proteus Infections; Pseudomonas Infections; Rats; Research; Starvation; Toxicology; Turpentine | 1964 |
LACK OF ENHANCED LYSIS OF FIBRINOGEN-I-131 BY ANTICOAGULANTS IN TUMOR-BEARING RATS.
Topics: Anticoagulants; Fibrinogen; Fibrinolysis; Heparin; Iodine; Iodine Isotopes; Lymphoma; Lymphoma, Non-Hodgkin; Metabolism; Neoplasms; Neoplasms, Experimental; Pharmacology; Radiometry; Rats; Research; Warfarin | 1964 |
IMMUNOLOGICAL REMOVAL OF CIRCULATING I-131-LABELED RABBIT ANTIBODY TO RAT FIBRINOGEN IN NORMAL AND TUMOR-BEARING RATS.
Topics: Animals; Fibrinogen; gamma-Globulins; Goats; Immune Sera; Iodine; Iodine Isotopes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Rabbits; Radioisotopes; Radionuclide Imaging; Rats; Research; Sarcoma; Sarcoma, Experimental | 1964 |
[THE BEHAVIOR OF DIFFERENT BLOOD COAGULATION FACTORS IN IRRADIATION OF GYNECOLOGICAL CARCINOMA WITH COBALT 60].
Topics: Blood Coagulation Factors; Blood Platelets; Coagulants; Cobalt; Cobalt Isotopes; Factor V; Factor VII; Female; Fibrinogen; Genital Neoplasms, Female; Hemostatics; Humans; Neoplasms; Prothrombin; Radiation Effects; Radioisotope Teletherapy | 1964 |
LOCALIZATION OF 131 I-LABELLED ANTIBODIES TO FIBRINOGEN IN HUMAN TUMORS.
Topics: Animals; Antibodies; Brain Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Fibrinogen; Humans; Iodine Isotopes; Neoplasms; Rabbits | 1964 |
[DATA TO THE DIAGNOSTIC VALUE OF FIBRINOGEN DETERMINATION IN MALIGNANT DISEASES].
Topics: Cyclophosphamide; Fibrinogen; Hodgkin Disease; Humans; Metaplasia; Myeloproliferative Disorders; Neoplasms; Prednisone; Primary Myelofibrosis; Silicotuberculosis; Splenic Diseases | 1964 |
[TUMOR GROWTH AND WOUND HEALING DISORDERS].
Topics: Animals; Blood Protein Electrophoresis; Coagulants; Fibrinogen; Fibrinolysis; Guinea Pigs; Hemostatics; Laparotomy; Neoplasms; Neoplasms, Experimental; Pathology; Proteins; Rats; Research; Wound Healing | 1964 |
[NEW TECHNICS OF TUMOR LOCALIZATION].
Topics: Coagulants; Fibrinogen; Hemostatics; Iodine Isotopes; Neoplasms; Rats; Research; Serum Albumin; Serum Albumin, Radio-Iodinated | 1965 |
[IS THERE A RELATIONSHIP BETWEEN THE CHOLESTEROL AND FIBRINOGEN CONTENT OF THE BLOOD?].
Topics: Adolescent; Cardiovascular Diseases; Child; Cholesterol; Fibrinogen; Geriatrics; Humans; Neoplasms | 1965 |
[COLLECTIVE STUDIES ON METHODS FOR THE EARLY DIAGNOSIS OF CANCER USING ISOTOPECHEMICAL COMBINATIONS. 1. DETECTION OF MALIGNANCIES].
Topics: Coagulants; Early Detection of Cancer; Fibrinogen; Hemostatics; Humans; Iodine Isotopes; Neoplasm Proteins; Neoplasms; Radioisotopes; Radionuclide Imaging; Research | 1965 |
[Fibrinogen in bronchial carcinoma].
Topics: Bronchi; Bronchial Neoplasms; Carcinoma, Bronchogenic; Fibrinogen; Humans; Neoplasms | 1955 |
[Studies on tumor scintigraphy with heterologous fibrinogen after labelling with I-131].
Topics: Animals; Coagulants; Fibrinogen; Hemostatics; Humans; Iodine; Iodine Radioisotopes; Neoplasms; Neoplasms, Experimental | 1962 |
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
Topics: Adenocarcinoma; Animals; beta-Alanine; Binding, Competitive; Cell-Matrix Junctions; Dose-Response Relationship, Radiation; Drug Design; Female; Fibrinogen; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Integrin alpha5beta1; Integrin alphaVbeta3; Integrins; Jurkat Cells; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasms; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Radioisotopes; Radionuclide Imaging; Receptors, Vitronectin; Sulfonamides; Tissue Distribution; Vitronectin; Yttrium Radioisotopes | 2003 |
Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Cell Division; Chemotaxis; Endothelium, Vascular; Fibrinogen; Fibroblast Growth Factor 2; Humans; Mice; Mice, Inbred BALB C; Microcirculation; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Recombinant Proteins; Skin; Vascular Endothelial Growth Factor A | 2004 |
Modulation of plasma fibrinogen levels in acute-phase response after hepatectomy.
Topics: Acute-Phase Reaction; Adult; Aged; Blood Chemical Analysis; Female; Fibrinogen; Hepatectomy; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasms; Postoperative Complications; Prognosis; Regression Analysis; Treatment Outcome | 2004 |
The incidence of disseminated intravascular coagulation in dogs with malignant tumor.
Topics: Animals; Disseminated Intravascular Coagulation; Dog Diseases; Dogs; Fibrinogen; Neoplasms; Partial Thromboplastin Time; Platelet Count; Prothrombin Time | 2004 |
Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form.
Topics: Antigens, CD; Cell Line, Tumor; Cell Membrane; Cell Transformation, Neoplastic; Complement C3b; Female; Fibrinogen; Humans; Membrane Cofactor Protein; Membrane Glycoproteins; Metalloproteases; Neoplasms; Reactive Oxygen Species | 2004 |
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.
Topics: Animals; Blood Platelets; Cell Survival; Fibrin; Fibrinogen; GTP-Binding Protein alpha Subunits, Gq-G11; Killer Cells, Natural; Lung; Mice; Mice, Knockout; Neoplasm Metastasis; Neoplasms; Platelet Activation; Thrombosis | 2005 |
Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation.
Topics: Adenocarcinoma; Animals; Blood Coagulation; Blood Platelets; Cell Communication; Cell Line, Tumor; Colonic Neoplasms; Fibrinogen; Fibrosarcoma; Hirudins; Humans; Lung; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Rats; Thrombin | 2004 |
Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression.
Topics: alpha-2-Antiplasmin; Antithrombins; Biotinylation; Caseins; Cloning, Molecular; Disease Progression; Extracellular Matrix; Fibrinogen; Glycosylation; Humans; Hydrogen-Ion Concentration; Kallikreins; Kinetics; Mass Spectrometry; Neoplasms; Neovascularization, Pathologic; Pichia; Plasminogen; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Serine Endopeptidases; Serpins; Substrate Specificity; Time Factors; Trypsin; Vitronectin | 2005 |
Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy.
Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Drug Design; Fibrinogen; Humans; Models, Biological; Neoplasm Metastasis; Neoplasms | 2007 |
Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation.
Topics: Adult; Area Under Curve; C-Reactive Protein; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Infections; Liver Diseases; Male; Middle Aged; Neoplasms; Pregnancy; Pregnancy Complications; Prognosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Analysis; Wounds and Injuries | 2007 |
Smoking, fibrinogen and cancer mortality.
Topics: Adult; Angiogenesis Inducing Agents; Black or African American; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; Pilot Projects; Proportional Hazards Models; Risk Factors; Smoking; United States | 2007 |
C-reactive protein as an acute phase protein in cancer patients.
Topics: Acute-Phase Proteins; Adolescent; Adult; Aged; Biomarkers, Tumor; C-Reactive Protein; Case-Control Studies; Diagnosis, Differential; Female; Fibrinogen; Humans; Infections; Male; Middle Aged; Neoplasms; Reference Values; ROC Curve; Severity of Illness Index; Statistics, Nonparametric | 2007 |
Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2).
Topics: Cell Proliferation; Drug Synergism; Fibrinogen; Fibroblast Growth Factor 2; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; RNA, Small Interfering; Tumor Cells, Cultured | 2008 |
[Study on the relationship between function of blood and tumor recurrence in oral squamous cell carcinomas].
Topics: Blood Coagulation; Carcinoma, Squamous Cell; Female; Fibrinogen; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasms; Partial Thromboplastin Time; Prothrombin Time; Thrombin Time | 2007 |
Networking with fibrinogen: a prerequisite for fibroblast growth factor-2 (FGF-2)-stimulated tumor growth?
Topics: Cell Proliferation; Fibrinogen; Fibroblast Growth Factor 2; Humans; Neoplasms | 2008 |
[Changes of prethrombotic state indexes in patients with malignant cancer].
Topics: Adult; Aged; Blood Coagulation; Blood Platelets; Case-Control Studies; Endothelin-1; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; P-Selectin; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Prothrombin Time; Thrombin Time; Tissue Plasminogen Activator | 2007 |
Impact of anaesthesia-surgery on D-dimer concentration and end-tidal CO2 and O2 in patients undergoing surgery associated with high risk for pulmonary embolism.
Topics: Aged; Anesthesia, General; Breath Tests; Carbon Dioxide; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Orthopedic Procedures; Oxygen; Postoperative Period; Prospective Studies; Pulmonary Embolism; Risk Assessment; Risk Factors; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Up-Regulation | 2008 |
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Topics: Aged; Aged, 80 and over; Antithrombin III; Antithrombins; Disseminated Intravascular Coagulation; Factor V; Factor XIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Peptide Hydrolases; Platelet Count; Thromboplastin; Triazines | 2008 |
131-I-labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials.
Topics: Antibodies; Antifibrinolytic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Isotopes; Iodine Radioisotopes; Melanoma; Neoplasms; Radionuclide Imaging; Sarcoma | 1967 |
[Significance of the laboratory diagnosis of hypercoagulability].
Topics: Blood Coagulation Tests; Cardiovascular Diseases; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Neoplasms; Partial Thromboplastin Time; Platelet Count; Postoperative Complications; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis | 1984 |
Radioiodinated fibrinogen distribution in cancer patients.
Topics: Bleomycin; Blood Coagulation; Cobalt Radioisotopes; Female; Fibrinogen; Half-Life; Heparin; Humans; Iodine Radioisotopes; Neoplasms; Radionuclide Imaging; Tissue Distribution | 1980 |
Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
Topics: Blood Coagulation; Breast Neoplasms; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Male; Monocytes; Neoplasms; Postoperative Period; Prostatic Hyperplasia; Thromboplastin; Thyroid Neoplasms; Time Factors; Urinary Bladder Neoplasms | 1984 |
[Possibilities of plasmapheresis treatment of metastasizing malignomas].
Topics: Antineoplastic Agents; Colonic Neoplasms; Female; Fibrinogen; Humans; Male; Neoplasm Metastasis; Neoplasms; Plasmapheresis; Prospective Studies; Random Allocation; Rectal Neoplasms | 1983 |
Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A.
Topics: Blood Coagulation Tests; Cardiovascular Diseases; Evaluation Studies as Topic; Fibrinogen; Fibrinopeptide A; Humans; Immunoenzyme Techniques; Neoplasms; Radioimmunoassay; Reference Values; Thrombosis | 1984 |
Activation of blood coagulation in cancer: Trousseau's syndrome revisited.
Topics: Antibodies; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Cell Adhesion; Cell Communication; Cyclooxygenase Inhibitors; Disseminated Intravascular Coagulation; Epoprostenol; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Indomethacin; Monocytes; Neoplasm Transplantation; Neoplasms; Syndrome; Thrombocytopenia; Thrombocytosis; Thromboembolism; Thromboplastin | 1983 |
[Cytostatic agent-induced increase of fibrinopeptide A levels].
Topics: Antineoplastic Agents; Fibrinogen; Fibrinopeptide A; Humans; Neoplasms; Thrombin | 1984 |
Does qualitatively altered fibrinogen contribute to the increased heparin precipitable fraction (HPF) in acute myocardial infarction (AMI)?
Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Blood Proteins; C-Reactive Protein; Fibrinogen; Fibronectins; Haptoglobins; Heparin; Humans; Myocardial Infarction; Neoplasms; Orosomucoid; Pulmonary Embolism; Sepsis | 1984 |
Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Topics: Antigen-Antibody Complex; Complement Activating Enzymes; Complement C1q; Evaluation Studies as Topic; Fibrinogen; Heparin; Humans; Immunoglobulin G; Immunoglobulin M; Iodine Radioisotopes; Methods; Neoplasms; Reference Standards; Serum Albumin | 1984 |
Is fibrinogen a marker of cancer progression?
Topics: Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms | 1983 |
Relationship between fibrinopeptide a (FPA) level and fibrinogen kinetics in patients with malignant disease.
Topics: Adult; Aged; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Male; Middle Aged; Neoplasms; Thrombin | 1983 |
Disseminated intravascular coagulation in geriatric patients.
Topics: Age Factors; Aged; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Japan; Leukemia; Neoplasms; Platelet Count; Sepsis | 1983 |
Measurement of fibrinogen degradation products by a sandwich enzyme immunoassay technique.
Topics: Abruptio Placentae; beta-Galactosidase; Chromatography, Gel; Cross Reactions; Escherichia coli; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoenzyme Techniques; Leukemia; Male; Neoplasms; Pregnancy | 1980 |
Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors.
Topics: Animals; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Fibrinogen; Fibrinolytic Agents; Kinetics; Mopidamol; Neoplasms; Phosphodiesterase Inhibitors; Platelet Count; Sulfinpyrazone; Warfarin | 1982 |
DIC: identification and management.
Topics: Blood Coagulation; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Heparin; Humans; Labor, Obstetric; Neoplasms; Pregnancy; Purpura, Thrombotic Thrombocytopenic; Snake Bites; Thrombin | 1982 |
Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth.
Topics: Aged; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Prognosis; Prothrombin Time; Warfarin | 1983 |
Coagulation abnormalities in dogs with neoplastic disease.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Dogs; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Neoplasms; Partial Thromboplastin Time; Thrombocytopenia | 1980 |
Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer.
Topics: alpha 1-Antitrypsin; Ceruloplasmin; Chemotaxis, Leukocyte; Fibrinogen; Haptoglobins; Humans; Immunosuppression Therapy; Lymphocyte Activation; Lymphocytes; Neoplasm Metastasis; Neoplasms; Orosomucoid; Serum Albumin | 1982 |
The extra nuclear control of mitosis & cell function. A theory of cellular organisation.
Topics: Adult; Aged; Azaserine; Cell Division; Cytoplasm; Electromagnetic Phenomena; Ethanol; Female; Fibrinogen; Hexoses; Hot Temperature; Humans; Insulin; Male; Middle Aged; Mitosis; Neoplasms; Streptokinase; Wound Healing | 1980 |
Immune-mediated platelet destruction and thrombocytopenia in patients with solid tumours.
Topics: Aged; Autoantibodies; Blood Platelets; Cell Survival; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Platelet Count; Splenectomy; Thrombocytopenia | 1982 |
Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
Topics: Adult; Aged; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Iodine Radioisotopes; Kinetics; Male; Middle Aged; Neoplasm Metastasis; Neoplasms | 1982 |
Catabolism and excretion of fibrinopeptide-A.
Topics: Adolescent; Adult; Aged; Animals; Brain Abscess; Burns; Child; Circadian Rhythm; Dogs; False Positive Reactions; Female; Fibrinogen; Fibrinopeptide A; Hemoglobinuria; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Myocardial Infarction; Neoplasms; Thrombin | 1982 |
Platelet and fibrinogen kinetics in canine tumors.
Topics: Adenocarcinoma; Animals; Blood Platelets; Dog Diseases; Dogs; Fibrinogen; Kinetics; Neoplasm Metastasis; Neoplasms; Platelet Count; Sarcoma; Thrombocytopenia; Thrombosis; Time Factors | 1981 |
Clinical significance of "circulating fibrin monomers'.
Topics: Chronic Disease; Ethanol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhagic Disorders; Humans; Male; Neoplasms; Thromboembolism; Time Factors | 1981 |
Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
Topics: Adolescent; Adult; Aged; Female; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Kinetics; Male; Middle Aged; Neoplasms; Thrombin | 1981 |
Isolation of fibrinogen-fibrin related antigen from human plasma by immuno-affinity chromatography: its characterization in normal subjects and in defibrinating patients with abruptio placentae and disseminated cancer.
Topics: Abruptio Placentae; Amino Acids; Antigens; Chromatography, Affinity; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Neoplasms; Pregnancy | 1980 |
Hemostatic function in cancer patients.
Topics: Adolescent; Adult; Aged; Antithrombin III; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Neoplasm Metastasis; Neoplasms | 1980 |
Coagulation factor XIII in plasma of patients with benign and malignant gynaecological tumours.
Topics: Aged; Blood Proteins; Factor XIII; Female; Fibrinogen; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms | 1994 |
Assessment of hypercoagulability in patients with cancer using the Sonoclot Analyzer and thromboelastography.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Blood Coagulation Disorders; Breast Diseases; Female; Fibrinogen; Hematology; Humans; Intestinal Diseases; Male; Middle Aged; Neoplasm Staging; Neoplasms; Platelet Count; Predictive Value of Tests; Sex Distribution; Thrombelastography | 1994 |
Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Disseminated Intravascular Coagulation; Endothelin-1; Endothelins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Neoplasms; Platelet Count; Protein Precursors; Prothrombin Time | 1994 |
Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
Topics: alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hemostasis; Humans; Infections; Leukemia; Neoplasms; Peptide Hydrolases; Platelet Count; Prothrombin Time; Retrospective Studies | 1999 |
A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibody Affinity; Enzyme-Linked Immunosorbent Assay; Epitopes; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gastrointestinal Diseases; Granulocytes; Humans; Inflammation; Leukocyte Elastase; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasms | 2000 |
Introduction: fibrinogen as a determinant of the metastatic potential of tumor cells.
Topics: Animals; Fibrin; Fibrinogen; Hemostasis; Humans; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating | 2000 |
Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis.
Topics: Biomarkers, Tumor; Case-Control Studies; Cross-Linking Reagents; Dimerization; Electrophoresis, Gel, Two-Dimensional; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Neoplasm Proteins; Neoplasms; Pleural Effusion, Malignant; Proteome; Tissue Distribution | 2001 |
Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American men.
Topics: Aged; Americas; Biomarkers; Cohort Studies; Fibrinogen; Follow-Up Studies; Heart Diseases; Humans; Japan; Male; Middle Aged; Myocardial Ischemia; Neoplasms; Prospective Studies; Risk Factors; Survival Rate | 2001 |
Plasma ascorbic acid and risk of heart disease and cancer.
Topics: Ascorbic Acid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Humans; Neoplasms; Risk Factors | 2001 |
Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Hemorrhage; Humans; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasms; Thrombocytopenia; Thrombosis | 2001 |
[Malignant tumor and hyperfibrinogenemia].
Topics: Biomarkers, Tumor; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Prognosis | 2002 |
Changes in blood viscosity and plasma proteins in carcinoma.
Topics: Alpha-Globulins; Beta-Globulins; Blood Proteins; Blood Viscosity; Fibrinogen; gamma-Globulins; Hematocrit; Humans; Neoplasms | 1977 |
Fibrinogen catabolism in the surgically treated patient and in those with postoperative venous thrombosis. Correlation of plasma fibrinogen chromatographic findings with 125I-labeled fibrinogen scan findings.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Aspirin; Chromatography, Agarose; Chromatography, Gel; Fibrinogen; Humans; Iodine Radioisotopes; Middle Aged; Neoplasms; Plasminogen; Postoperative Complications; Radionuclide Imaging; Thrombophlebitis | 1977 |
Comparison of oncophilic radiopharmaceuticals, *I-fibrinogen, 67Ga-citrate, 111In-bleomycin, and *I-bleomycin in tumor-bearing mice.
Topics: Animals; Bleomycin; Citrates; Female; Fibrinogen; Gallium Radioisotopes; Indium; Iodine Radioisotopes; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasms; Radioisotopes; Radionuclide Imaging | 1977 |
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies.
Topics: Alpha-Globulins; Blood Sedimentation; Breast Neoplasms; Copper; Fibrinogen; Humans; Iron; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Multiple Myeloma; Neoplasms | 1978 |
Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis.
Topics: Adult; Aged; Animals; Blood Coagulation Disorders; Carcinoma, Bronchogenic; Carcinoma, Ehrlich Tumor; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Thromboembolism; Thromboplastin | 1975 |
[Kinetics of I-131 fibrinogen in cancer patients: pharmacological approach].
Topics: Aspirin; Blood Coagulation; Fibrinogen; Fibrinolytic Agents; Heparin; Indomethacin; Iodine Radioisotopes; Kinetics; Neoplasms; Platelet Aggregation; Prednisone; Pyridines; Thiophenes | 1977 |
[Hyperfibrinogenemia in oncological patients].
Topics: Child; Fibrinogen; Fibrinolysis; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms; Wilms Tumor | 1977 |
Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells.
Topics: Binding Sites; Cell Membrane; Cell Transformation, Viral; Cells, Cultured; Fibrin; Fibrinogen; Fibroblasts; Fibronectins; Fluorescent Antibody Technique; Humans; Immune Sera; In Vitro Techniques; Neoplasms; Protein Binding; Receptors, Drug; Simian virus 40 | 1979 |
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue.
Topics: Animals; Blood Coagulation; Cattle; Enzyme Precursors; Factor VII; Factor X; Fibrinogen; Humans; Neoplasms; Peptide Hydrolases; Rabbits; Thromboplastin | 1975 |
Simple, sensitive method for measuring plasmin and plasminogen activity in plasma.
Topics: Enzyme Activation; Female; Fibrinogen; Fibrinolysin; Humans; Hydrogen-Ion Concentration; Kinetics; Liver Diseases; Male; Neoplasms; Plasminogen; Pregnancy; Pregnancy Trimester, First; Spectrophotometry; Streptokinase; Thrombosis | 1975 |
[Radioisotope diagnosis of postoperative deep-vein thrombosis of the leg in oncological patients].
Topics: Adult; Aged; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Neoplasms; Postoperative Complications; Radioisotope Dilution Technique; Thrombophlebitis | 1977 |
Immunoglobulin deposits in the dermo-epidermal junction zone. Nosographic occurrence in a number of medical diseases.
Topics: Arthritis, Rheumatoid; Autoantibodies; Collagen Diseases; Complement System Proteins; Diagnosis, Differential; Endocrine System Diseases; Fibrinogen; Fluorescent Antibody Technique; Humans; Hypersensitivity; Immunoglobulins; Infections; Kidney Diseases; Lupus Erythematosus, Systemic; Neoplasms; Rheumatoid Factor; Skin; Skin Diseases | 1979 |
Tumor interaction with the fibrinolytic system.
Topics: Aminocaproates; Fibrinogen; Fibrinolysis; Freezing; Humans; Methods; Neoplasm Metastasis; Neoplasms; Tissue Preservation | 1979 |
[Postoperative thrombosis of the deep veins of the legs in oncological patients].
Topics: Adult; Age Factors; Aged; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Neoplasms; Postoperative Complications; Radionuclide Imaging; Thrombophlebitis; Time Factors; Veins | 1979 |
[Prospects of short-term sequential immunomodulation with levamisole and Corynebacterium parvum in neoplastic pathology in the aged].
Topics: Aged; Blood Sedimentation; Complement System Proteins; Female; Fibrinogen; Humans; Immunoglobulins; Immunotherapy; Leukocyte Count; Levamisole; Lymphocytes; Male; Middle Aged; Mucoproteins; Neoplasms; Propionibacterium acnes | 1979 |
The effect of tumor localizing porphyrins on the conversion of fibrinogen to fibrin.
Topics: Blood Coagulation; Fibrin; Fibrinogen; Humans; Neoplasms; Porphyrins; Time Factors; Whole Blood Coagulation Time | 1979 |
[Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Iodine Radioisotopes; Neoplasms; Radioimmunoassay; Thrombosis | 1979 |
Use of 125I-fibrinogen kinetic data to detect disseminated intravascular coagulation and deposition of fibrin in patients with metastatic cancer.
Topics: Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Mathematics; Neoplasm Metastasis; Neoplasms | 1977 |
[Postoperative thromboses and embolisms in oncological patients].
Topics: Adult; Blood Viscosity; Esophageal Neoplasms; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Neoplasms; Postoperative Complications; Stomach Neoplasms; Thromboembolism; Time Factors | 1978 |
Fibrinogen kinetics in patients with neoplastic disease.
Topics: Adult; Aged; Female; Fibrinogen; Half-Life; Humans; Kinetics; Leukemia; Lymphoma; Male; Middle Aged; Models, Biological; Neoplasms | 1978 |
Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro.
Topics: Brain; Brain Neoplasms; Cell Line; Cells, Cultured; Culture Media; Epithelial Cells; Epithelium; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Indicators and Reagents; Meningeal Neoplasms; Meningioma; Neoplasms; Plasminogen; Plasminogen Activators; Urokinase-Type Plasminogen Activator | 1978 |
Smoking and risk factors in deep vein thrombosis.
Topics: Adult; Aged; Aging; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasms; Risk; Smoking; Thromboembolism; Thrombophlebitis | 1978 |
[Concentration of fibrinogen in the plasma of children with malignant tumors].
Topics: Child; Child, Preschool; Fibrinogen; Hodgkin Disease; Humans; Infant; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Retroperitoneal Neoplasms | 1975 |
Deep venous thrombosis and multiple regression analyses of the influence from various clincial factors on the fibrinogen half-life in surgical patients, using 125I-fibrinogen.
Topics: Blood Transfusion; Female; Fibrinogen; Half-Life; Humans; Infections; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neoplasms; Regression Analysis; Surgical Procedures, Operative; Thrombophlebitis; Time Factors | 1977 |
[Abnormalities of coagulation and fibrinolysis in patients with neoplasms (author's transl)].
Topics: Adult; Aged; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neoplasms | 1977 |
Blood fibrinolytic activity in cancer patients.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Neoplasms; Serum Globulins; Thrombin | 1976 |
Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Protein Electrophoresis; Densitometry; Electrophoresis, Polyacrylamide Gel; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Molecular Weight; Neoplasms; Surgical Procedures, Operative | 1976 |
Effect of fibrinogen on aggregation of red cells and on apparent viscosity of artificial thrombi in haemophilia, myocardial infarction, thyroid disease, cancer and control systems: effect of ABO blood groups.
Topics: ABO Blood-Group System; Blood Coagulation Tests; Blood Group Antigens; Blood Sedimentation; Blood Viscosity; Cell Aggregation; Erythrocytes; Fibrinogen; Hemophilia A; Humans; Microcirculation; Myocardial Infarction; Neoplasms; Regression Analysis; Rheology; Thyroid Diseases | 1975 |
Changes in blood viscosity and plasma proteins in carcinoma.
Topics: Blood Viscosity; Fibrinogen; Humans; Neoplasms; Serum Globulins | 1975 |
[Value of the use of radioactive fibrinogen in man].
Topics: Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Fibrinogen; Graft Rejection; Humans; Iodine Radioisotopes; Kinetics; Neoplasms; Nephritis; Thrombophlebitis | 1975 |
[Metabolism and distribution of I-131 fibrinogen in cancer patients with disseminated intravascular coagulation syndrome].
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Humans; In Vitro Techniques; Iodine Radioisotopes; Mathematics; Neoplasms | 1975 |
The significance of extracapillary proliferation. Clinicopathological review of 60 patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Complement C1; Female; Fibrinogen; Follow-Up Studies; Glomerulonephritis; Hematuria; Humans; Immunoglobulins; Kidney; Kidney Glomerulus; Male; Middle Aged; Neoplasms; Oliguria; Prognosis; Proteinuria | 1976 |
Radioimmunoassay of fibrinopeptide A-clinical applications.
Topics: Blood Preservation; Blood Specimen Collection; Burns; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinopeptide A; Freezing; Humans; Immune Sera; Neoplasms; Plasma; Radioimmunoassay; Streptokinase; Thrombin; Thrombophlebitis; Uremia; Venous Pressure; Wounds and Injuries | 1976 |
Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Topics: alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Cholangitis; Disseminated Intravascular Coagulation; Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Neoplasms; Peptide Fragments; Peptide Hydrolases; Peritonitis; Prothrombin | 1992 |
[Locoregional therapy in patients with malignant pleural effusion--two different types of "BAC therapy"].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drainage; Drug Delivery Systems; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Neoplasms; Pleural Effusion; Thrombin | 1992 |
Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Glycoproteins; Hepatitis; Humans; Immunoblotting; Immunoenzyme Techniques; Integrins; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms; Platelet Membrane Glycoproteins; Receptors, Immunologic; Receptors, Vitronectin; Reference Values; Vitronectin | 1991 |
Blood coagulation abnormalities during adoptive immunotherapy with interleukin-2 (r-Met Hu IL-2 [ala 125]).
Topics: Blood Coagulation; Blood Coagulation Factors; Fibrinogen; Humans; Immunotherapy; Interleukin-2; Neoplasms; Partial Thromboplastin Time; Pilot Projects; Prothrombin Time; Recombinant Proteins | 1991 |
[Studies on the pathogenesis of hypercoagulability in patients with arterial thrombosis and malignancy].
Topics: Aged; Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Female; Fibrinogen; Humans; Male; Middle Aged; Monocytes; Neoplasms; Peptide Hydrolases; Thrombosis | 1990 |
The cause of coagulopathy after peritoneovenous shunt for malignant ascites.
Topics: Adult; Aged; Aged, 80 and over; Ascites; Blood Coagulation Disorders; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Neoplasms; Partial Thromboplastin Time; Peritoneovenous Shunt; Platelet Count; Prothrombin Time | 1990 |
[Analysis of adhesive proteins on the surface membrane of platelet in malignant neoplasm].
Topics: Blood Platelets; Cell Membrane; Fibrinogen; Fibronectins; Flow Cytometry; Humans; Neoplasms; Platelet Adhesiveness | 1990 |
Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels.
Topics: Antineoplastic Agents; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Neoplasms; Partial Thromboplastin Time | 1990 |
[Fibrin pleurodesis in malignant pleural effusions].
Topics: Adult; Aged; Antifibrinolytic Agents; Aprotinin; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Renal Cell; Drainage; Female; Fibrinogen; Heparin; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Pleura; Pleural Effusion; Posture; Prognosis; Thrombin | 1985 |
[Clinical significance of fibrinogen analysis in blood coagulation tests].
Topics: Adolescent; Adult; Age Factors; Aged; Blood Coagulation Tests; Child; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Immunodiffusion; Inflammation; Middle Aged; Neoplasms; Nephelometry and Turbidimetry; Reference Values; Specimen Handling | 1989 |
[Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42].
Topics: Aged; Blood Coagulation; Cerebral Infarction; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Peptide Fragments | 1989 |
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans.
Topics: Blood Coagulation Tests; Drug Evaluation; Fibrinogen; Fibrinopeptide A; Hemostasis; Humans; Neoplasms; Protein C; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1989 |
[The phenomenon of relative resistance to heparin].
Topics: Adult; Aged; Blood Coagulation Tests; Drug Resistance; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Half-Life; Heparin; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Thromboembolism | 1987 |
[Effect of therapy with cytostatic drugs on the hemostasis system in patients with small cell and non-small cell bronchial cancers, malignant lymphomas and plasmacytomas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fibrinogen; Fibrinopeptide A; Hodgkin Disease; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Plasmacytoma | 1986 |
[Hyperviscosity in cancer patients and huo xue hua yu therapy].
Topics: Adolescent; Adult; Aged; Blood Sedimentation; Blood Viscosity; Electrophoresis; Female; Fibrinogen; Hematocrit; Humans; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Middle Aged; Neoplasms; Plant Extracts; Plants, Medicinal | 1985 |
Coagulation and fibrinogenolysis during whole-body hyperthermia.
Topics: Antithrombin III; Blood Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Humans; Hyperthermia, Induced; Neoplasms | 1988 |
[Cerebral ischemic accidents and chronic disseminated intravascular coagulation of cancerous origin].
Topics: Adenocarcinoma; Adult; Cerebral Infarction; Cystadenoma; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Platelet Count; Prothrombin; Urinary Bladder Neoplasms | 1988 |
Modulatory effect of the gastrointestinal tract (gut) on fibrinolysis and fibrinogen derivatives.
Topics: Arm; Cholelithiasis; Fibrinogen; Fibrinolysis; Humans; Intestines; Neoplasms; Plasminogen; Portal Vein | 1987 |
Possible role of fibrinogen in the aggregation of white blood cells.
Topics: Animals; Bacterial Infections; Cell Adhesion; Cell Aggregation; Coronary Disease; Female; Fibrinogen; Humans; In Vitro Techniques; Inflammation; Leukocytes; Male; Neoplasms; Rabbits | 1987 |
Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Topics: Collagen Diseases; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Thromboembolism | 1987 |
Abnormalities of blood coagulation tests in patients with cancer.
Topics: Blood Coagulation Tests; Cardiovascular Diseases; Fibrinogen; Fibrinopeptide A; Humans; Neoplasms; Platelet Count; Thrombin; Warfarin | 1987 |
Hyperfibrinogenemia as a cause of prolonged thrombin clotting time.
Topics: Adult; Aged; Blood Coagulation Tests; Female; Fibrinogen; Humans; In Vitro Techniques; Infections; Kinetics; Male; Middle Aged; Neoplasms; Prospective Studies; Prothrombin Time; Retrospective Studies; Thrombin Time | 1986 |
The interaction of tumour-localizing porphyrins with collagen, elastin, gelatin, fibrin and fibrinogen.
Topics: Animals; Cattle; Collagen; Elastin; Fibrin; Fibrinogen; Gelatin; Humans; In Vitro Techniques; Mice; Neoplasms; Porphyrins; Proteins | 1985 |
Regulation of extravascular coagulation by microvascular permeability.
Topics: Animals; Blood Coagulation; Bradykinin; Capillary Permeability; Fibrin; Fibrinogen; Guinea Pigs; Histamine; Neoplasms; Skin; Skin Physiological Phenomena | 1985 |
[Hemostatic indices of oncological patients with different forms of jaundice].
Topics: Antithrombin III; Cholestasis; Cholestasis, Intrahepatic; Female; Fibrinogen; Hemostasis; Humans; Neoplasms; Plasminogen; Plasminogen Activators | 1985 |
[Clotting, fibrinolytic and complement activities in pleural fluids in carcinomatous and tuberculous pleuritis].
Topics: Blood Coagulation Factors; Complement System Proteins; Diagnosis, Differential; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Pleural Effusion; Pleurisy; Tuberculosis, Pleural | 1985 |
[Fibrinopeptide A in cancer patients and its changes with chemotherapy].
Topics: Adult; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Disorders; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Neoplasms | 1985 |
Deep vein thrombosis of the leg. Is there a "high risk" group?
Topics: Adult; Age Factors; Aged; Body Weight; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Neoplasms; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis; Thyroid Function Tests; Varicose Veins | 1970 |
[Hyperfibrinogemia in malignant tumors in children].
Topics: Adolescent; Blood Coagulation Disorders; Child; Child, Preschool; Fibrinogen; Hodgkin Disease; Humans; Infant; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Wilms Tumor | 1974 |
Fibrinogen and metastases.
Topics: Animals; Cell Line; Culture Media; Female; Fibrinogen; gamma-Glutamyltransferase; Humans; In Vitro Techniques; Lysine; Mitochondria; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Oxygen Consumption; Plasmacytoma; Pregnancy; Thrombin; Thrombosis; Wound Healing | 1974 |
[Cryoglobulin (cryofibrinogen) in tumor patients].
Topics: Blood Protein Disorders; Breast Neoplasms; Cryoglobulins; Diagnosis, Differential; Fibrinogen; gamma-Globulins; Humans; Lung Neoplasms; Neoplasms | 1966 |
Platelet adhesiveness in postoperative deep-vein thrombosis.
Topics: Aged; Blood Platelet Disorders; Blood Platelets; Female; Fibrinogen; Humans; Male; Methods; Middle Aged; Neoplasms; Postoperative Complications; Serum Albumin, Radio-Iodinated; Thrombophlebitis | 1969 |
[Metastasis of cancer and blood coagulation system].
Topics: Animals; Blood Coagulation; Carcinoma, Ehrlich Tumor; Female; Fibrinogen; Fibrinolysin; Humans; Male; Neoplasm Metastasis; Neoplasms; Plasminogen; Rats; Thrombophlebitis | 1969 |
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
Topics: Adult; Agglutination Tests; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral; Erythrocytes; False Negative Reactions; False Positive Reactions; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemagglutination Inhibition Tests; Hodgkin Disease; Humans; Immunoassay; Immunodiffusion; Kidney Diseases; Liver Cirrhosis; Lymphoma, Non-Hodgkin; Male; Methods; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Staphylococcus | 1970 |
The clinical significance of fibrinogen-fibrin-related antigen in serum.
Topics: Abruptio Placentae; Antigens; Blood Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Liver Cirrhosis; Neoplasms; Pregnancy | 1971 |
Simplified microestimation of fibrinogen and seromucoid in plasma.
Topics: Adolescent; Adult; Aged; Borates; Copper; Female; Fibrinogen; Humans; Hypercholesterolemia; Indicators and Reagents; Male; Microchemistry; Mucoproteins; Neoplasms; Perchlorates; Sodium Hydroxide; Sulfates; Tartrates | 1967 |
Lack of thrombohemorrhagic phenomena complicating childhood solid tumors.
Topics: Adolescent; Age Factors; Blood Coagulation Tests; Blood Platelet Disorders; Disseminated Intravascular Coagulation; Factor V; Factor VIII; Fibrin; Fibrinogen; Humans; Kidney Neoplasms; Lymphatic Diseases; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Osteosarcoma; Retinoblastoma; Rhabdomyosarcoma; Sarcoma, Ewing; Wilms Tumor | 1974 |
About increase of aggregation of red cells with an increase of temperature in normal and abnormal blood (i.e. cancer). Effect of ABO blood groups and proteins.
Topics: ABO Blood-Group System; Anticoagulants; Blood Donors; Blood Group Antigens; Blood Proteins; Blood Sedimentation; Blood Viscosity; Cell Aggregation; Edetic Acid; Erythrocytes; Fibrinogen; Hematocrit; Hot Temperature; Humans; Myocardial Infarction; Neoplasms; Serum Albumin; Vascular Diseases | 1973 |
Blood coagulation studies in patients with cancer.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Child; Child, Preschool; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Multiple Primary; Prothrombin Time; Thrombin; Thrombocytopenia; Time Factors | 1974 |
Evaluation of patients with increased fibrinolytic split products (FSP) in their serum.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Child; Collagen Diseases; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Humans; Infections; Kidney Diseases; Leukemia; Male; Middle Aged; Neoplasms; Prothrombin Time; Thrombin; Vascular Diseases | 1974 |
Studies on blood coagulation in cancer patients.
Topics: Aged; Blood Coagulation; Blood Coagulation Tests; Child, Preschool; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prothrombin Time | 1974 |
Dynamic viscoelasticity of blood during clotting in health and disease.
Topics: Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Sedimentation; Blood Viscosity; Diabetes Mellitus; Elasticity; Female; Fibrinogen; Hematocrit; Humans; Infections; Leukemia, Myeloid; Male; Neoplasms; Polycythemia Vera; Rheology; Thrombosis | 1973 |
Altered coagulability in tumor patients: introduction.
Topics: Blood Coagulation Disorders; Fibrinogen; Humans; Neoplasms | 1974 |
Hemostasis in malignancy.
Topics: Blood Cell Count; Blood Coagulation; Blood Platelets; Cell Survival; Fibrinogen; Fibrinolytic Agents; Hematopoiesis; Hemorrhage; Humans; Kinetics; Neoplasms; Thrombocytopenia; Thromboembolism; Thrombophlebitis | 1974 |
"Hypercoagulable state" in children with acute leukemia or disseminated solid tumors.
Topics: Adenocarcinoma; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Child; Factor IX; Factor VII; Factor XI; Fibrinogen; Humans; Kidney Neoplasms; Leukemia, Lymphoid; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Remission, Spontaneous; Sarcoma, Ewing | 1973 |
Subclinical immune complexes in the glomeruli of kidneys postmortem.
Topics: Antigen-Antibody Complex; Autopsy; Basement Membrane; Capillaries; Complement System Proteins; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Kidney Glomerulus; Leukemia; Leukemia, Myeloid; Lymphoma; Microscopy, Electron; Neoplasms; Primary Myelofibrosis | 1974 |
Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature.
Topics: Adolescent; Adult; Aged; Alcoholism; Blood Protein Disorders; Cryoglobulins; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Leukocyte Count; Male; Middle Aged; Neoplasms; Poisoning; Thromboembolism; Thrombosis; Trypsin Inhibitors; Wounds and Injuries | 1972 |
Parallel determinations of FDP and fibrin monomers with various methods.
Topics: Animals; Blood Coagulation Tests; Ethanol; Evaluation Studies as Topic; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Neoplasms; Peptide Hydrolases; Postoperative Complications; Postpartum Period; Pregnancy; Protamines; Snakes; Thrombin; Venoms | 1972 |
Platelet and fibrinogen consumption in man.
Topics: Blood Cell Count; Blood Platelets; Catheterization; Cell Survival; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolytic Agents; Heart Valve Prosthesis; Hemolytic-Uremic Syndrome; Heparin; Humans; Inflammation; Neoplasms; Postoperative Complications; Purpura, Thrombotic Thrombocytopenic; Sepsis; Surgical Procedures, Operative; Thromboembolism; Thrombophlebitis; Thrombosis; Vascular Diseases | 1972 |
[Malignant tumor scintigraphy using 131-I-labelled fibrinogen].
Topics: Adult; Aged; Female; Fibrinogen; Humans; Iodine Isotopes; Male; Middle Aged; Neoplasms; Radionuclide Imaging | 1972 |
[Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
Topics: Adolescent; Adult; Angina Pectoris; Chronic Disease; Diabetes Mellitus; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Neoplasms | 1972 |
Correlation of hyperfibrinogenemia with major thromboembolism in patients with cancer.
Topics: Adolescent; Adult; Aged; Autopsy; Blood Coagulation Disorders; Child; Child, Preschool; Female; Femoral Vein; Fibrinogen; Humans; Iliac Vein; Leukemia; Lymphoma; Male; Middle Aged; Neoplasms; Pulmonary Embolism; Retrospective Studies; Thromboembolism; Thrombophlebitis; Vena Cava, Inferior | 1973 |
[Hemostatic system in patients with malignant neoplasms].
Topics: Blood Coagulation Disorders; Fibrinogen; Hemostasis; Humans; Neoplasms | 1973 |
Fibrinolysis in human malignant tumours.
Topics: Breast Neoplasms; Colonic Neoplasms; Esophageal Neoplasms; Fibrin; Fibrinogen; Fibrinolysis; Gallbladder Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms | 1973 |
Disseminated intravascular coagulation in cancer patients: supportive evidence.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Factor V; Female; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Male; Middle Aged; Neoplasms | 1973 |
[Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
Topics: Agglutination Tests; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Neoplasms; Staphylococcus | 1973 |
The arginine content in fibrin clots and fibrinolysis in neoplastic diseases.
Topics: Arginine; Fibrin; Fibrinogen; Fibrinolysis; Humans; Neoplasm Proteins; Neoplasms; Protein Binding | 1973 |
Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery.
Topics: Age Factors; Anesthesia, Epidural; Body Height; Body Weight; Female; Fibrinogen; Genital Diseases, Female; Heparin; Humans; Injections, Subcutaneous; Iodine Radioisotopes; Neoplasms; Postoperative Complications; Thrombophlebitis; Vagina; Varicose Veins | 1973 |
The clinical significance of the plasminogen level.
Topics: Adolescent; Adult; Afibrinogenemia; Blood Coagulation Tests; Contraceptives, Oral; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Infections; Liver Cirrhosis; Male; Menstruation; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Sex Factors; Surgical Procedures, Operative; Thrombosis; Wounds and Injuries | 1973 |
Localization of tumours with 131I-antifibrinogen antibodies.
Topics: Adenocarcinoma; Animals; Antibodies; Brain Neoplasms; Carcinoma, Squamous Cell; Female; Fibrinogen; Hemangioma; Humans; Iodine Radioisotopes; Liver Neoplasms; Meningioma; Neoplasms; Rabbits; Radionuclide Imaging; Tuberculosis; Uterine Cervical Neoplasms | 1973 |
Incidence of hyperfibrinogenemia in 1961 patients with cancer.
Topics: Blood Coagulation Factors; Blood Coagulation Tests; Carcinoma; Fibrinogen; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Neoplasms; Retrospective Studies; Sarcoma | 1973 |
Bleeding disorders during surgery.
Topics: Adrenal Cortex Hormones; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Extracorporeal Circulation; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemostasis; Humans; Liver Diseases; Male; Neoplasms; Purpura, Thrombocytopenic; Surgical Procedures, Operative; Thrombocytopenia; Transfusion Reaction | 1974 |
Determination of fibrinogen degradation products in serum and urine as a new diagnostic tool.
Topics: Antigens; Blood; Blood Protein Disorders; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Kidney Diseases; Kidney Transplantation; Leukemia; Liver Diseases; Neoplasms; Pregnancy; Thromboembolism | 1971 |
Separation and estimation split "products" of fibrinogen and fibrin in human serum.
Topics: Aminocaproates; Aprotinin; Cellulose; Chromatography; Chromatography, Gel; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Immunoelectrophoresis; Liver Diseases; Macroglobulins; Neoplasms; Plasminogen; Streptokinase; Thrombin; Thrombosis | 1967 |
[Afibrinogenemia in dogs].
Topics: Adenocarcinoma; Afibrinogenemia; Animals; Blood Coagulation Tests; Dog Diseases; Dogs; Female; Fibrinogen; Immunoelectrophoresis; Lymphatic Diseases; Male; Mammary Glands, Animal; Neoplasm Metastasis; Neoplasms; Thrombocytopenia | 1971 |
Clinical experience with determination of fibrinogen degradation products.
Topics: Acute Kidney Injury; Arteritis; Female; Fibrinogen; Hemorrhage; Humans; Immunodiffusion; Kidney Failure, Chronic; Liver Diseases; Methods; Neoplasms; Pneumonia; Pregnancy; Pregnancy Complications; Thromboembolism | 1971 |
The biological half-life of I-131 fibrinogen.
Topics: Adult; Aged; Aminocaproates; Arteriosclerosis; Blood Coagulation; Coronary Disease; Factor X; Female; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Hypothyroidism; Immunodiffusion; Iodine Isotopes; Male; Neoplasms | 1965 |
Prevention of deep vein thrombosis by intermittent pneumatic compression of calf.
Topics: Adult; Age Factors; Aged; Air; Anesthesia, General; Female; Fibrinogen; Hospitals, General; Hospitals, Teaching; Humans; Iodine Radioisotopes; Leg; Length of Stay; Male; Middle Aged; Neoplasms; Obesity; Postoperative Complications; Preoperative Care; Pressure; Thrombophlebitis; Time Factors | 1972 |
The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
Topics: Antibodies; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Hyperthyroidism; Kidney Diseases; Latex; Liver Diseases; Methods; Microspheres; Neoplasms; Pulmonary Embolism | 1972 |
Detection of fibrinogen-fibrin degradation products by counterelectrophoresis.
Topics: Blood Coagulation Tests; Contraceptives, Oral; Female; Fibrin; Fibrinogen; Humans; Immunoelectrophoresis; Liver Cirrhosis; Methods; Neoplasms; Postoperative Complications; Precipitin Tests; Sepsis; Thrombin | 1972 |
[Blood sedimentation in malignant tumors. Evaluation of differentiation potential of tumor and infection-induced increase in sedimentation rate as indicated by Gross and co-workers].
Topics: Blood Sedimentation; Diagnosis, Differential; False Positive Reactions; Fibrinogen; Glycerylphosphorylcholine; Humans; Inflammation; Lysophosphatidylcholines; Methods; Neoplasms; Phosphatidylcholines; Phospholipases; Temperature | 1971 |
[Mass screening for early diagnosis of malignant tumors with hematochemical examinations].
Topics: Acid Phosphatase; Copper; Fibrinogen; Humans; Liver; Mass Screening; Methods; Neoplasm Metastasis; Neoplasms; Prothrombin; Time Factors; Transaminases | 1971 |
[Analysis of fibrinogen in the ascitic and pleural fluids and its clinicopathological significance].
Topics: Antigens; Ascitic Fluid; Fibrinogen; Fibrinolysis; Humans; Immunoelectrophoresis; Neoplasms; Pleural Effusion; Proteins | 1971 |
[First results with a spectrum of diagnostic tests for cancer].
Topics: Antigen-Antibody Reactions; Blood Sedimentation; Calcium; Cytodiagnosis; Endopeptidases; Fibrinogen; Humans; Iron; Ketoglutaric Acids; Magnesium; Malate Dehydrogenase; Methods; Neoplasm Proteins; Neoplasms; Phospholipids; Precipitin Tests | 1970 |
[On the application of 131-I-antifibrinogen to the diagnosis of malignant tumors].
Topics: Adult; Animals; Antibodies; Color; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasms; Rabbits; Radiography; Radionuclide Imaging | 1967 |
Selective uptake of radionuclides as a basis for tumor detection.
Topics: Antigen-Antibody Reactions; Brain Neoplasms; Capillary Permeability; Chromium; DNA; Fibrinogen; Humans; Iodine Isotopes; Liver; Liver Neoplasms; Neoplasm Metastasis; Neoplasms; Osteosarcoma; Pancreas; Phosphorus Isotopes; Radioisotopes; Radionuclide Imaging; Selenium; Spleen; Strontium Isotopes; Technetium; Thyroid Gland; Thyroid Neoplasms | 1969 |
Eight years of experience with massive blood transfusions.
Topics: Abdominal Injuries; Adolescent; Adult; Age Factors; Aneurysm; Blood Coagulation Disorders; Blood Group Incompatibility; Blood Platelet Disorders; Blood Transfusion; Child; Coombs Test; Factor V Deficiency; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Homeostasis; Humans; Infections; Liver Cirrhosis; Middle Aged; Neoplasms; Pancreatitis; Prothrombin Time; Retrospective Studies; Rupture; Shock; Vascular Diseases; Wounds and Injuries | 1971 |
[Cancer, hypercoagulability and thrombosis].
Topics: Aprotinin; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Blood Transfusion; Factor VIII; Fibrinogen; Heparin; Humans; Neoplasms; Thrombosis | 1971 |
Chronic intravascular coagulation (IFC) syndrome.
Topics: Blood Coagulation Disorders; Chromium Isotopes; Chronic Disease; Fibrinogen; Hemangioma; Hemoglobinuria, Paroxysmal; Humans; Iodine Isotopes; Liver Diseases; Neoplasms; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia | 1969 |
[Fibrinogen elevation in malignant tumors--an unspecific symptom].
Topics: Animals; Benzopyrenes; Fibrinogen; Neoplasms; Rats; Sarcoma, Experimental | 1969 |
Fibrinolysis, thromboplastin activity and localization of radioiodinated fibrinogen in experimental tumors.
Topics: Animals; Fibrinogen; Fibrinolysis; Iodine Isotopes; Neoplasms; Neoplasms, Experimental; Rats; Thromboplastin | 1970 |
[Immunologic serum diagnosis of human tumors using the "3-D-test"].
Topics: Adult; C-Reactive Protein; False Negative Reactions; False Positive Reactions; Female; Fibrinogen; Humans; Male; Methods; Neoplasms; Serologic Tests | 1970 |
Fibrinogen degradation products.
Topics: Cerebrovascular Disorders; Disseminated Intravascular Coagulation; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Pulmonary Embolism; Vascular Diseases | 1971 |
[Rapid determination of plasma fibrinogen with protamine sulfate].
Topics: Fibrinogen; Humans; Methods; Mononuclear Phagocyte System; Neoplasms; Protamines; Streptokinase | 1967 |
[State of the anticoagulant system in patients with cancer as an indication of the reactivity of the organism].
Topics: Anticoagulants; Antithrombins; Blood Coagulation; Breast Neoplasms; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Lung Neoplasms; Neoplasms; Skin Tests; Stomach Neoplasms | 1968 |
[Paper and agar electrophoresis results of pathologic plasma proteins with specific reference to fibrinogens].
Topics: Blood Protein Disorders; Blood Protein Electrophoresis; Fibrinogen; Hepatitis A; Humans; Immunoelectrophoresis; Liver Cirrhosis; Neoplasms | 1968 |
Comparative studies of blood coagulation and platelet aggregation in patients with cancer and nonmalignant diseases.
Topics: Adenine Nucleotides; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Factor V; Factor VIII; Fibrinogen; Humans; Neoplasms; Prothrombin Time; Thrombin; Thromboplastin | 1969 |
[Comparison of the results of the Brdicka reaction with fibrinogen level and fibrinolysis of plasma euglubolins for the diagnosis of malignant neoplasms].
Topics: Fibrinogen; Fibrinolysis; Gastrointestinal Neoplasms; Hodgkin Disease; Humans; Lung Neoplasms; Methods; Neoplasms; Peptic Ulcer; Polarography | 1969 |
Recognition and treatment of intravascular coagulation.
Topics: Anticoagulants; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Child, Preschool; Erythrocyte Aggregation; Factor V; Factor VIII; Fibrinogen; Hemangioma; Hemolysis; Heparin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infections; Leukemia; Neoplasms; Purpura; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Uremia | 1969 |
[The role of the thrombocytes in the induction of intravascular coagulation].
Topics: Animals; Blood Coagulation Disorders; Blood Platelets; Busulfan; Fibrin; Fibrinogen; Hemolysis; Injections, Intravenous; Kidney Glomerulus; Models, Biological; Neoplasms; Platelet Adhesiveness; Purpura; Rabbits; Sepsis; Shock; Shwartzman Phenomenon; Sulfonic Acids; Thrombocytopenia | 1969 |
Metabolic aspects of imbalance in hemostasis: consumption of factors in disease. Discussion.
Topics: Blood Coagulation; Cardiovascular Diseases; Fibrinogen; Hematologic Diseases; Neoplasms | 1965 |
[The radioactive fibrinogen for the diagnosis of tumors in man].
Topics: Diagnosis, Differential; Fibrinogen; Humans; Inflammation; Iodine Radioisotopes; Methods; Neoplasms | 1965 |
[On the utilization of coagulatory physiologic and immunologic processes for the concentration of radioactivity in tumors].
Topics: Animals; Antibodies; Diagnosis, Differential; Fibrinogen; Humans; Injections, Intravenous; Iodine Isotopes; Neoplasms; Radionuclide Imaging; Rats; Sarcoma, Experimental; Sarcoma, Yoshida | 1965 |
[Concentration of I-131-fibrinogen in tumor tissues].
Topics: Animals; Cattle; Diagnosis, Differential; Fibrinogen; Humans; Injections, Intravenous; Iodine Isotopes; Lymphatic Metastasis; Methods; Neoplasms; Radionuclide Imaging; Rats; Sarcoma, Yoshida | 1965 |
Studies with iodine-131-labeled antibody to human fibrinogen for diagnosis and therapy of tumors.
Topics: Animals; Antibodies; Fibrinogen; Goats; Humans; Injections, Intravenous; Iodine Isotopes; Iodine Radioisotopes; Neoplasm Regression, Spontaneous; Neoplasms; Rabbits; Radionuclide Imaging | 1966 |
Differentiation of malignant neoplasms from other bone lesions using radioactive fibrinogen.
Topics: Fibrinogen; Humans; Iodine Isotopes; Mercury; Neoplasms | 1966 |
Distribution of 95Nb labelled plasma & fibrinogen in tumour bearing rats.
Topics: Animals; Blood Proteins; Fibrinogen; Male; Neoplasms; Niobium; Radioisotopes; Rats | 1966 |